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1.

PURPOSE

As with most new procedures,
sion of vasopressin for
bleeding does entail
the

fear

the

Among

to be directly exposed

the hepatic artery

to vasopressin during celiac

axis or superior mesenteric artery
Using

these has been

ischemia may result secondary to de¬

creased hepatic artery blood flow if
were

infusions.

the dog as my experimental model

the changes

(9;106;132;173)

I have

studied

in blood flow through the hepatic artery with

non-cannulating electromagnetic flow probes during
direct intra-celiac
mined the pre-

infusion of vasopressin.

and post-infusion angiograms

who underwent therapeutic

Administration Hospital
found in the

the

then exa¬

of patients
infusion

at the West Haven Veterans'

to correlate

the results which

laboratory in dogs with actual

in man.

I

intra-celiac vasopressin

for gastro-intestinal bleeding

servations

infu¬

the control of gastro-intestinal

certain risks.

that hepatic

intra-arterial

I

clinical ob¬

2.

INTRODUCTION

In order to fully understand both my laboratory work
and its

clinical

significance

reader to be knowledgeable
vasculature,

about vasopressin,

and angiography,

understanding of

it would be useful

as well

the

the hepatic

as having a clear

the pertinent experiments which comprise

the background against which my results must be
and evaluated.

for

I have attempted to provide

tion in the following

interpreted

this

informa¬

sections.

VASOPRESSIN

Vasopressin is

synthesized in cell bodies

ventricular and supraoptic nuclei o’f
migrates along

the axons of

as neurosecretory granules
perivascular spaces
of

downward growth from the
cin,

which causes

also

these nerve cells

to be

stored

in the nerve cell endings
which

and

near

is part

the pituitary gland formed as a
floor of

the diencephalon.

Oxyto¬

contraction of uterine muscle and contrac¬

tion of myoepithelial cells
is

the hypothalamus

in the neurohypophysis,

the posterior lobe of

in the para¬

in

the alveoli of mammary glands

synthesized and stored by an

posterior hypophyseal

system.

(19;45)

identical hypothalamoThe control of

3.
vasopressin release

is mediated through osmoreceptors

(increased plasma osmolarity leads
release),(95)
leads

volume receptors

to

increased vasopressin

(increased plasma volume

to decreased vasopressin release),

by emotional

and physical

stress.

(76)

as well

as

(95)

Oliver first demonstrated the pressor effect of pit¬
uitary extract in 1895,
of

the extract caused

perfusion of

noting

a rise

that intravenous

in blood pressure and

the extract through the vascular

pithed frog greatly decreased the flow of
In 1928,

eighty times

one was

as potent as

Powdered Pituitary and
ciple.

that

system of

fluid.

Kamm separated two active principles

posterior pituitary;

infusion

a

(137)

from the

a pure pressor principle

the

International

Standard of

the other was a pure oxytocic prin¬

He found the pressor principle

to also be respon¬

sible for the anti-diuretic action of pituitary extract
(96)
1913.

which had first been described by von den Velden in
(190)

In 1953,

DuVigneaud identified and

arginine-8-vasopressin

(62)

hormone

except for the pig

in all mammals

amus, where

arginine

in the

to form lysine vasopressin.

which

is

of

the natural ocurring
and the hippopot¬

side chain is replaced by lysine
The vasopressins

octapeptides with a closed ring of
side chaiir of

synthesized

three amino acids.

are

all

five amino acids

(182)

The chemical

cyclic

and a
activity

the compound depends on both the cyclic pentapeptide and

the tripeptide

side chain;

thus,

opening of

the circle or

4
removal of
example)

the terminal glycine amine group

rapidly inactivates

(by trypsin,

the vasopressin.

(76)

The third common type of vasopressin available
addition to

for

in

the lysine-8-vasopressin and arginine-8-vaso-

pressin is phenylalanine-lysine-vasopressin

(PLV-2)

a syn¬

thetic compound formed by substituting phenylalanine for
tyrosine in position two of

lysine vasopressin.

Phenylal¬

anine-lysine-vasopressin has been found to have the

same

pressor effect as

the natural occurring vasopressins,

but

anywhere from 1/2

to 1/70

PLV-2

is,

therefore,

(15;182)

their anti-diuretic

effect;

felt to have a selective pressor effect.

Lysine and arginine vasopressins

have equivalent

pressor and anti-diuretic effects when compared with each
other.
Although we are mainly concerned with

the effect of

vasopressin on the gastro-intestinal vasculature,
briefly review some of
of vasopressin is
from the

its other properties.

to control

The main effect

the reabsorption of

collecting tubules of

the kidney.

by vasopressin doses many hundreds of

This

times

we should

free water
is

smaller than

those doses required to produce a pressor response
and

achieved

(47),

it is probably the only true physiologic function of

vasopressin in mammals.
ever,

(76)

In pharmacologic doses,

vasopressin has many additional

Gruber and Kountz,

and in 1961,

effects.

Drapanas,

found

In

how¬

1930,

that vaso-

5.
pressin caused constriction of
53;85)

the coronary arteries

in addition to a decreased heart rate

systemic arterial blood pressure.

The

fall

atropine and,

therefore,

be due to both a parasympathetic response
blood pressure

as well

as

it was
to the

(85)

Vasopressin is

metabolism rate,

known to decrease

and

(46;50;53;63;71;187)

the

The decrease
in cardiac

the decrease

in coronary blood flow and the reflex bradycardia.

mals

Von Cyan first reported pulsus bigeminus

injected with pituitary extract

pressin has been noted to cause
ing prolonged P-R interval,
ST-T wave changes,
Ruskin has

car¬

to a direct depressive effect of

vasopressin on the myocardium in addition to

In 1898,

also

the basal

in cardiac output is associated with a decrease
work and is probably due

increased

in unanesthetized

cardiac oxygen consumption,

diac output in mammals.

felt to

Vasopressin was

noted to cause Cheynes-Stokes respirations
(84)

the vagi or

a direct depressive effect of

vasopressin on the myocardium.

dogs.

and increased

in heart rate

was only partially prevented by severing of
administration of

(26;

(85);

in ani¬
then vaso¬

several EKG changes

sino-atrial block,

and various

includ¬

non-specific

irregular rhythms.

suggested using vasopressin as

out latent coronary vascular

since

(63)

(155)

a test to bring

insufficiency;

pain following vasopressin injection as his

using anginal
end point he ob¬

tained results which correlated well with the Master's

ex-

.

6
ercise test.

(155)

In 1936,

Collins

the use of vasopressin to eliminate
cholecystography;

vasopressin

and Root reported on
intestinal gas during

(5-20 Units)

increased the

peristaltic activity and propulsive movement of
(76)

There have been reports,

however,

known EKG or clinical history of
suffered acute
procedure.

ed injections

infarctions during

Dearing and Essex in

of vasopressin in cats,

focal histologic changes
in the

of patients with no

cardiac disease who have

and fatal myocardial

(124;172)

sub-endocardial

the bowel.

1944,

were able

in the myocardium,

layers of muscle of

associated with significant EKG changes.

by repeat¬
to produce

most prominent
the

left ventricle,

(124)

Due

effect on gastro-intestinal motility vasopressin has
been used to relieve intestinal distention.
also reduces

the volume of

juices

as well

(157)

insulin,
158;159)

salivary,

as reducing

secretions.

secondary to

also

Vasopressin

(109;152;

in blood flow

increased systemic

blood pressure and active vasodilatation of
is

its

biliary and pancreatic

transient increase

through cutaneous vessels,

(26)

to

the volume of histamine,

and food stimulated gastric
An initial and

this

the vessels,

followed by a prolonged cutaneous vasoconstriction during

vasopressin infusions.

(35;192)

Local

infiltrations of

vasopressin have been used in plastic,

dental

surgery to both prolong

local

the effects

and to provide a bloodless

field

of

and cervical
anesthetics

(104;140;168);

vasopressin

.

7
was

found to be superior to

for this

purpose

in that vasopressin produced pallor without the

central

cyanosis

that was

adrenaline

seen with adrenaline;

it

is

therefore

felt that adrenaline

causes more tissue damage

with poorer healing.

(100)

and necrosis

Vasopressin has been found to

exert a direct effect on the

thyroid gland indentical with

that of

TSH

increase

appropriate doses of
in the

level of

(69)

as well

serum cortisol

cortex.

(110;128)

causing

an

felt to be medi¬

ated via the release of ACTH and not to be
on the adrenal

as

Both of

a direct effect
these effects

are

only seen with exogenous pharmacologic levels of vasopressin.
Vasopressin has

also been found to protect pancreatic blood

flow during experimental
was not given,

acute pancreatitis;

pancreatic flow decreased by 40-60% but with

vasopressin the pancreatic
attributed to

flow remained stable.

This was

the maintenance of good aortic perfusion pressure

and to a redistribution of
to

when vasopressin

the areas of

arterial

inflammation.

(144)

flow within the pancreas
Finally,

many of

the

above

mentioned actions of vasopressin are manifested clinically
during vasopressin infusions by skin pallor,
nausea,

bowel movements,

by several hours of
Vasopressin,

abdominal

cramps,

and urgent micurition followed

anti-diuresis.

(151;166;182)

in pharmacologic doses,

also has

signi¬

ficant effects upon the gastro-intestinal

and hepatic vas¬

cular systems which make

treatment of

it useful

in the

.

8
gastro-intestinal bleeds
sources.

from both arterial

It is known that vasopressin causes peripheral

vasoconstriction with a decrease
cular arteries of
oral

and variceal

artery.

the body,

(187)

in blood flow in the mus¬

such as

the branches of

A similar effect is

supplying the gastro-intestinal

seen in the

system.

83;87;106;134;135;142;165)

60%,

to decrease

to decrease

83;135;165)

the

by 20%

to

70%.

on the hepatic
several

blood flow
an increase
hepatic

reporting

an increase

(3;37;63;83;87;90;135;141;169)
in hepatic artery pressure

systemic arteries

is

in the body,

(142)

ments

the hepatic

the

involving

introduction since

clear,

with

in hepatic artery

while others

seen in the rest of
(53;98;117;165)

I will discuss

flow

and a decrease

others report an inconsistent response of
to vasopressin.

(3;37;82;

The effect of vasopressin

artery blood flow has been less

artery blood flow as

(3;83;135;

the gastric artery blood

(3;14;25;50;135;142)

investigators

superior

inferior mes¬

the splenic artery blood flow,

and to decrease

arteries

(3;5;6;37;50;53;

enteric artery blood flow by equivalent amounts,
165)

fem¬

Vasopressin has

been shown to decrease the blood flow through the
mesenteric artery by approximately

the

report
in

the

and still

the hepatic artery

all of

these experi¬

artery in detail

at the end of

they are directly related to my re¬

search .
Vasopressin has

also been found to be very effective

.

9
in lowering portal venous pressure
as well

as

in man.

166;170;178;182)
effect is

in experimental

animals

(48;53;56;58;62;83;90;98;141;149;165;
The predominant feeling is

secondary to

a decrease

that this

in splenic,

gastric,

super¬

ior mesenteric and inferior mesenteric arterial blood flow
secondary to vasoconstriction in these vessels
a result less blood is
a

"medical"

portal

reaching

shunt is

created;

(3;32;36;57;83;97;134;142;169;178)

ie.,

the main effect

to be pre-portal.

Several

have claimed to demonstrate

response of

that as

the portal vein and thus

of vasopressin on the portal vein seems

however,

so

investigators,

an additional

the portal vein to vasopressin.

direct

(59;120;135;

169)
It is because of
and its

its

arterial vasoconstrictive effects

ability to reduce portal venous pressure

pressin has become a clinical
gastro-intestinal bleeding.
control hemorrhage during
century when it was
in & ten minute

(181)

treatment of

Vasopressin was

first used to
the

in intravenous doses of

tumors,

the bleeding.

Nevertheless,

10

units
secondary

fungal diseases

The results were rather good,

to determine

twentieth

treat brisk hemoptysis

tuberculosis,

clinician time

perfectly clear

in the

the first half of

infusion to

to bronchiectasis,
and so on.

used

tool

that vaso¬

giving

the

and treat the primary cause of
for reasons which are not

this procedure is no

longer used

in the

.

10
treatment of

severe hemoptysis.

the successful use of
ment of

In 1955,

Kehne reported on

intravenous vasopressin

in the

treat¬

two patients with cirrhosis who were bleeding from

esophageal varices.
trolled;

In both cases

the first patient re-bled

six months,

responding well

the bleeding was well

five times over the next

to vasopressin each time,

the second patient underwent excision of his varices
well post-operatively.

(98)

and
and did

There have been many other reports

on the use of vasopressin in the control of hematemesis
esophageal varices

since Kehne's

133;153;162;166;182)
vasopressin controls
pressure,

thus either

It is

original work.

felt by the above

the bleeding by reducing
stopping,

mechanism,

the bleeding

site.

suggested by Aronsen,

causes constriction of the

is

that

the portal venous
the

so that a clot is

A possible additional
that vasopressin actually

by ligating

He

the portal vein

the animals developed porto-systemic communications

in the form of para-esophageal and submucosal
ices.

researchers

lower esophageal musculature.

created portal hypertension in dogs
fourteen of

from

(43;122;132;

or at least decreasing

flow of blood through the esophageal varices
able to form over

con¬

esophageal var¬

During intravenous vasopressin infusion it was

noted

by angiography that the submucosal esophageal varices dis¬
appeared but the para-esophageal collaterals dilated;
felt that this

it was

response was due to the contractile effect

.

11
of vasopressin on the smooth muscle of
closing off

the feeding

mucosal varices
culature and

as

and draining radicles

of

the

sub¬

they passed through the esophageal mus¬

thereby causing more blood to flow through the

para esophageal collaterals.

(3)

More recently Baum and Nusbaum,
selective angiography to diagnose
bleeding

the esophageal wall,

(see angiography)

who were working with

sites of gastro-intestinal

infused vasopressin intra¬

arterially through the catheter which they had used for
angiographic demonstration of
was

the bleeding

the

site and which

still positioned in the bleeding vessel.

They found

that the direct infusion of vasopressin into a bleeding artery
within the gastro-intestinal
bleeding from that vessel
decreased blood flow,
lation factors

which then allowed
They have

the normal coagu¬

successfully infused

superior mesenteric artery to control

bleeding esophageal varices

as well as

small bowel ulcers.

infused vasopressin into the gastric

to control Mallory Weiss

tears,

bleeding gastric ulcers;

into

the gastroduodenal

a bleeding hepatoma.

artery

hemorrhagic gastritis

control bleeding duodenal ulcers,
to control

to cessation of

secondary to vasoconstriction and

to function.

vasopressin into the

They have also

system led

and

artery to

and into the hepatic artery

(9;11;47;130;132;133)

Baum

and Nusbaum have also used vasopressin intra-operatively
to control blood

loss during porta-caval

shunt surgery. (9)

.

12
In general

they have been able

it was possible

to

to control most bleeds where

infuse the vasopressin directly into

vessel which was bleeding,

proximal

to the

Vasopressin will not control bleeding
of

the main stem of

the bleeding

site

is

a major vessel;

the

site of bleeding.

secondary to erosion

it is most effective when

from a peripheral branch of

the artery

since vasopressin is best at producing peripheral vasocon¬
striction.

Baum and Nusbaum usually infuse vasopressin

(Pitressin)

at a dosage rate of

minute;

at these rates

and only minimal
the

they claim to

cardiac and renal

infused vasopressin is

system.

rapidly

to use much

necessary with intravenous
Both Rosch and Meves,
vasopressin into

the

effects

tachyphylaxis
since most of

inactivated
to

smaller doses
infusions.

the bleeding

laboratories,

infuse

superior mesenteric artery to control
However,

for arterial gastro¬

they use epinephrine with propanolal

infusions.

(122;153)

pressin infusions with the epinephrine

In comparing
infusions

basically equivalent vasoconstrictor properties
enteric arteries,

site

than would be

the frequent occurrence of re-bound bleeding

the epinephrine

ephrine

in the portal

(191)

in different

bleeding esophageal varices.
intestinal bleeds

Pressor Units/cc./

see no

By infusing directly proximal

they are able

spite of

0.1-0.2

in
after

the vaso¬

Rosch

found

in the mes¬

but post infusion blood flow in the epin¬

treated vessel was

145% of pre-infusion level

for

13

.

three minutes while blood flow in the vasopressin treated
vessel was

still only 80% of pre-infusion level

after the infusion was ended.
Intra-arterial

(154)

infusion of vasopressin is

used to control bleeding

also being

from non-gastro-intestinal

Slezak reported infusing vasopressin into
artery of

forty minutes

a patient who was bleeding

the

sites.

internal

from a branch of

vessel which had been eroded away by carcinoma.

iliac
that

He hypothe¬

sized that in addition to the vasoconstrictive effect of vaso¬
pressin,

small

clots may have embolized from the tip of

catheter

and moved distally to occlude

He also emphasized the

importance of

plus EKG and CVP monitoring

the bleeding

careful

to guard against cardiac and

probably at the arteriolar

Peter injected india ink into

creased capillary filling,

just proximal

arterioles.

Texter,

found

segments of

found de^

implying that the constrictive

effect is probably

to various

level.

the gastric and superior mesen¬

teric arteries of dogs receiving vasopressin and

ed

(171)

action of vasopressin on the gastro¬

intestinal vasculature is

(142)

site.

fluid balance

renal complications during vasopressin infusions.
The exact site of

the

to the capillaries

using pressure

in small

transducers

connect¬

the superior mesenteric artery

the greatest increase of vascular resistance and pressure

during
ized to

intra-arterial

infusions

the small vessel

of vasopressin to be

segments

of

local¬

the superior mesenteric

.

14
artery.

He found that vasopressin had no

effect on the
(178)

constrictive

superior mesenteric vein and

Peskin injected small glass beads

its branches.

into

the

superior

mesenteric artery and collected them in the portal vein to
evaluate arterio-venous

anastomoses

He noted a significant decrease
trieved during

the

intravenous

small bowel.

in the number of beads

re¬

infusion of vasopressin and

concluded that the arterio-venous
in response

in the

to the vasopressin.

shunts were closing down

(141)

Actually/

however,

Peskin's results would also be consistent with arteriolar
constriction proximal

to

the

arterio-venous anastomoses.

Delaney injected 20 micron'radioactive

spheres

into

superior mesenteric artery and recovered only 3%
portal vein and liver.

He

the amount of blood flowing
in the

small bowel.

the percent of
and he

through arterio-venous

Intravenous

action.

(49)

channels

pitressin did not alter
channels

Altura directly observed muscu¬

(arterio-venous

a rat during

anastomoses)

in

the mesen-

topical vasopressin administration by

using an image splitting

television microscope recording

He noted that the metarterioles did constrict when

exposed to vasopressin,
less

represented

flow through the arterio-venous

lar metarterioles

system.

in the

concluded that they were not the primary site of

vasopressin's

tary of

assumed that this

the

sensitive

but the response was

two

to

ten times

than the response of mesenteric arterioles

.
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to topical vasopressin.

(1)

Thus,

it seems

that the main

constrictive effect of vasopressin is on the
We must also remember,
contraction of

however,

arterioles.

that vasopressin causes

the muscular layers of

the gastro-intestinal

tract and that the flow of blood in vessels passing

through

this muscular layer will be markedly decreased during
muscular contractions.
tance to

(3;63)

Although of

the arteriolar constriction,

this

secondary

the
impor¬

latter effect also

will reduce gastro-intestinal blood flow.
On a more cellular
vasopressin is

still

level,

however,

a mystery.

dogs with sympathectomies

the mechanism of

Adrenalectomized dogs

from L-2

and

caudally still respond

to vasopressin with a decrease in blood flow as monitored
in the

femoral

artery.

(71)

noted that vasopressin's

Both Corliss

effects

and Ericsson have

in pharmacologic doses

are antagonized by neither adrenergic blocking agents
vascular denervation.

(46;62)

However,

Gardiner found

in dogs with circulatorily isolated carotid sinuses,
ed vagi and complete
tone there was
vasopressin

lack of

recordable

nor

splanchnic

that

sever¬

sympathetic

no pressor response to physiologic levels of

(0.01 unit/kg.).

In those animals with severed

vagi but with good sympathetic tone
sensitivity to vasopressin.

(70)

there was

This

an increased

latter work suggests

that at least at physiologic levels vasopressin does depend
on an intact sympathetic

system in order to exert

its

pressor

.
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effect.

Lewis and Reit found that pharmacologic doses of

vasopressin

(2 units/kg.)

in cats were able to stimulate

neither the superior cervical ganglion nor the adrenal
medulla as monitored by movement of normal and denervated
nictitating membranes respectively.

(113)

Hertting and

Suko found that pharmacologic doses of vasopressin were
unable to release

labelled noradrenaline from sympath¬

etic nerve endings in the isolated cat spleen.

(91)

Finally,

it has been shown that vasopressin does not change the acti¬
vity of post ganglionic sympathetic nerves of the celiac
ganglion but that phenoxybenzamine and/or phentolamine will
inhibit the pressor response of physiologic doses of vaso¬
pressin.

(180)

Thus,

it seems that vasopressin's effect

is not mediated through the sympathetic nervous system;
however,

it does seem that at least at physiologic doses

the catecholamines themselves help to potentiate vaso¬
pressin's pressor effect.

This is supported by the find¬

ing that non-pressor doses of vasopressin will potentiate
the pressor effect of catecholamines.
be mediated through the 3'5'
shown by Orloff in 1962,

(7)

This may all

cyclic AMP system which was

to be involved with vasopressin's

effect on water movement through the toad bladder.

(76)

Cyclic AMP is found in vascular tissue and it is known that
catecholamines increase the level of cyclic AMP in many
tissues.

Possibly vasopressin and the catecholamines po-

17.
tentiate each other’s
of

effects by increasing

the availability

cyclic AMP.
There has been very little work concerning the

tionship between vasopressin and electrolytes,
it has been shown that magnesium sulfate will
induced constriction of
The half
teen minutes,

the

although

inhibit vasopressin
(112)

approximately fif¬

being removed from the plasma and

mainly during passage through the

the

(76)

superior mesenteric artery.

life of vasopressin in man is

initial passage of

interrela¬

inactivated

liver and kidneys.

(76)

a pharmacologic dose of vasopressin through

liver is not sufficient to modify its pressor effects.

The mean half

life of vasopressin in the dog

is

centration of vasopressin given,

implying

involved with vasopressin removal
In rats a

total of

50% of

(183)

5.4 minutes

and over a broad range this does not seem to vary with

167)

The

the con¬

that the mechanism

is not readily saturated.(108;

an injected dose of vasopressin

is cleared by the kidneys,

but only

6-7% of

can be found in the urine,

implying

that approximately 90% of

vasopressin taken up by the kidneys

is

The

another

liver accounts

given while the
gans
it is

for clearance of

last

in the body.(75)

inactivated in

10% of vasopressin is
Vasopressin is

confined to the plasma and is

the dose of vasopressin

40% of

the

the kidneys.

the vasopressin

cleared by other or¬

transported by the blood where

relatively free

from any in¬

activation except in pregnant females who do have a vasopressinase
which can inactivate the vasopressin in plasma to

a minor

.
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extent.

(107)

Clark,

in 1928,

first noted that repeated injections

of vasopressin had progressively diminishing pressor effects.
(36)

Razzak noted a similar

as an initial bolus of

tachyphylactic response;

where¬

3-5 units of vasopressin in dogs

caused a 50% decrease in portal venous pressure

the

third

bolus of vasopressin at twice the dosage caused only a 25%
decrease in pressure.
we are not seeing

(149)

Patil,

however,

suggested

that

true tachyphylaxis with vasopressin.

Tachyphylaxis means

a decreased response to repeated doses

of a drug secondary to increased receptor

saturation.

Sev¬

eral drugs are able to offset the tachyphylactic effect of
vasopressin:

oubain does

ephedrine does

this by increasing

it by inhibiting coronary vasoconstriction

and reserpine does

it by blocking reflexes.

which has no cardiotonic effects

that we are dealing with a

Thus,

tachyphylaxis

still not settled,

in patients

Patil

is

"pseudo tachyphylaxis"

due to cardiac fatigue rather than receptor
While the question is

Methoxamine,

is unable to offset the

tachyphylactic effect of vasopressin.
suggesting

cardiac output,

saturation.(138)

Nusbaum noted no

receiving repeated doses of

0,1-

0.2 units/minute of vasopressin for gastro-intestinal bleeds.
(132)
Finally,

I would

like to discuss

cations of vasopressin therapy.

some of

the compli¬

It should be noted

again

.
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that all of

the above mentioned effects of vasopressin are

seen at pharmacologic doses;
is

only the

seen at physiologic levels.

anti-diuretic effect

The complications

and side

effects of vasopressin therapy are actually the many diff¬
erent functions of vasopressin which were enumerated above.
These include facial pallor,

nausea,

defecation and uterine cramps,

eructations,

all of which are readily

controlled by decreasing the vasopressin dose.
More serious

complications

bosis with bowel
hypertension,

fluid retention.
warned of
necrosis

(76;151;166;182)

include mesenteric venous

infarction

anginal

flatus,

(150),

attacks,

(26;124;172)

EKG changes,

myocardial
Finally,

bradycardia,

infarction and

several

the potential hazard of hepatic

throm¬

authors have

ischemia and

secondary to vasopressin's- effect on hepatic ar¬

tery blood flow.

(9;132;173;106)

to find an actual reference

Although

in the

I have been unable

literature of hepatic

ischemia secondary to vasopressin infusion,

Nusbaum,

in

answering a question in one of his most recent articles
referred to a case of

liver necrosis

in a patient from

Bellevue with portal hypertension who had received a vaso¬
pressin infusion for several days.
unrecognized occlusion of

Nusbaum hypothesized

the celiac axis

arteriosclerotic disease so

on the basis of

that the entire

infusion of

vasopressin went from the superior mesenteric artery through
collaterals

to the hepatic arterial

system causing hepatic

.

20
ischemia and necrosis.
cautious

(132)

Baum and Nusbaum are especially

about infusing vasopressin into the hepatic artery:

"If one of

the branches of

the superior mesenteric
be advanced beyond

the hepatic artery arises

artery the tip of

the origin of

the catheter must

the hepatic artery in order

to prevent a decrease in arterial blood flow to
(9);
of

"Care must be taken to avoid direct or

the hepatic

ly infused due

artery"

(9);

"The celiac axis

the

such as

liver"

indirect infusion
is not direct¬

to the danger of hepatic necroses"

It is quotations

from

(132).

the above which stimulated my in¬

terest in this research project,

for

if

it could be estab¬

lished that vasopressin does not represent a threat to
hepatic artery blood flow then it would follow that there
is no danger of

hepatic

ischemia and necrosis during

infusions of vasopressin.

celiac

This would be clinically signi¬

ficant in that celiac catheterization is much easier and
quicker than super-selective catheterization of
gastric,

splenic,

patient who

or gastro-duodenal

is bleeding acutely this

ficant in the overall picture of

arteries,

the

left

and in a

time factor is

signi¬

therapeutic management

and ultimate recovery.
Before discussing my specific

experiment,

is necessary to review what is known of
lar

system,

able to

since only with this

interpret my results

however,

it

the hepatic vascu¬

information will we be

and hypothesize about what

.
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mechanisms might be responsible for what we are

seeing.

HEPATIC VASCULAR SYSTEM

The

liver is

supplied by two afferent blood vessels,

the hepatic artery and portal vein,

which enter the

at the hilum with the common bile duct.
tures branch together as
dividing

they penetrate the

then gives off
send branches

liver mass,

that the portal vein

smaller interlobular branches which finally
into

the

lobule where they subdivide

a network of intralobular sinusoids.
the central vein of

the

hepatic veins,

which are

course of

lobule which feeds

The

clear.

It is known that throughout its

some pre-sinusoidal

artery and portal vein

course

the

the

less

the hepatic
the

'

the bile ducts.

enter the portal vein so

that

there

communication between the hepatic
(19;34),

although

two vessels makes

or flow differences

empty

the

is

a capillary network which supplies

From this network venules

form

channels of

the hepatic artery branches

hepatic connective tissue and the walls of

work between the

into

into one of

the main efferent

liver.

artery gives off

to

These sinusoids

sublobular veins which eventually empty

is

three struc¬

into interlobar and then interlobular branches.

It is well accepted by all observers

into

All

liver

could be

the capillary net¬

it unlikely that pressure

transmitted from one vessel

.
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to

the other at this

level.

The rest

the arterial blood probably empties
via hepatic arterioles.

(and major part)

of

into the hepatic sinusoids

(45;103)

Although it is known that the portal vein supplies
most of

the hepatic blood flow,

ment as

to the total amount supplied by the hepatic artery.

The following
hepatic
3.6%

figures give

an idea of

artery contribution to

(73),

26-32%

50% with mean of

(116),
26%

artery blood flow,
pressure.

Thus,

30%

(160),

however,

there has been some disagree¬

total

the general range of
liver blood flow:

(27;28),
34%

12.6-24.5%

(164),

40%

(74).

varies with the

Herrick and Mann in 1938,

hepatic artery contributed 10-90% of

(17),

29.3±
14%-

The hepatic

systemic blood
found

that the

total hepatic blood

flow and Grayson found that at a systemic blood pressure
of

110 mmHg

in rats

total blood flow,
hepatic

artery was

the hepatic artery contributed

but at a systemic pressure of
responsible for

80% of

is probably due to
enabling

it to decrease its

ulate,

however,

is

the

130 mmHg

the flow.

(80)

the he¬
This

autoregulation within the hepatic artery,
resistance when perfusion pressure

is decreased thereby maintaining
vein,

80 mmHg

total hepatic

blood flow while at a systemic pressure of
patic artery contributed only 30% of

50% of

steady flow.

The portal

supplied by vessels which cannot autoreg-

and therefore,

when the

lowered the mesenteric,

systemic blood pressure

splenic and gastric

arteries

is

are

.
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poorly perfused and as
so

a result the portal venous flow drops

that the hepatic artery's relative contribution to total

hepatic blood flow is
fusion pressure of

increased.

Conversly,

the hepatic artery is

when the per¬

increased autoreg¬

ulation maintains hepatic artery blood flow at a fairly
constant level by increasing
key to autoregulation is

the vascular resistance.

that blood flow and perfusion pressure

are not a linear relationship.
mechanism of hepatic

(23;41;88;175;176)

in hepatic

innervation of
vein lacks

artery pressure;
the liver.

this

(88)

and thus,

It seems

that the portal
flow by regulating

in the face of portal pressure

in the portal vein pressure and flow

are a linear relationship and there
(23;101;174;175)

triggered by a

it is not dependent on

ability.to maintain its

its vascular resistance
changes,

The

artery autoregulation is probably a

myogenic constriction in the vessel walls
rise

The

is no autoregulation.

This will be discussed later in more detail

in relation to reciprocal portal vein and hepatic

artery

flows.
Although the hepatic
25% of

the total

32-100% of
of

70%.

artery supplies on the average only

liver blood flow it is responsible for

total hepatic oxygen uptake,

(21;83)

If

oxygen content of
volume percent.

the hepatic artery is

the hepatic vein falls

(17)

with a mean value

However,

constricted the
to

less

than one

when the portal venous

flow

.

24
is markedly reduced during vasopressin infusion the hepatic
oxygen consumption is not decreased since the hepatic
is able to maintain it at normal

levels.

(48)

artery

Also recall

that the hepatic artery is responsible for the nutrition
and oxygenation of

the bile ducts

and liver connective

tissue so

that a loss of hepatic arterial blood flow could

be lethal

secondary to necrosis of

tures.

(86)

This

hepatic branches but distal
(to eliminate most of

is

to

the collateral

in the rabbit.

died the liver was necrotic
and filled with foul

and all

to

the

its

all of

Cameron found

(34)

In the animals which

and the

abdomen was distended

smelling gas and

spore forming bacilli

which has been identified with the alpha

found throughout the abdominal
(177)

circulation)

(40;93; 147)

toxin of Clostridium Perfringens

liver.

ligated proximal

If

the right gastric artery

the dogs die within a few days.

and lecithinase,

liver struc¬

is confirmed by experimental data.

common hepatic artery of dogs

similar results

these basic

It seems

its branches

type A organisms,

cavity and within the necrotic

that ligation of

lowers

were

the hepatic artery

the hepatic oxygen content to

such a degree

that anaerobic bacteria are

erate.

(148)

These animals

stores

and become hypoglycemic in an effort to maintain

an adequate metabolic state.

able to prolif¬

also deplete their glycogen

(34; 40)

penicillin is given to these animals

Interestingly,
for ten days

if

after

.
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hepatic artery ligation they do well
Presumably,

penicillin prevents

overgrowth and within the
collateralization of

the

the

and do not die.

(148;177)

anaerobic bacterial

ten day period sufficient arterial
liver

is

established so that the

hepatic oxygen content can be maintained at a high enough
level

to prevent anaerobic bacterial proliferation once

penicillin is

stopped.

that ligation of

This

the hepatic

stages over several weeks
contribute to

the

is

further supported by the

artery and

permits

its branches

in

collateral vessels

to

its branches

ligated yet the animal

Analogous

can live.

(91)

have been found with ligation of
This

is

pressin does

all very relevant

to my research,

artery with the possible

total hepatic blood

130 ml./minute/100 gram of
blood flow is

bove

the

it

the

flow in most mammals

liver.

(83)

This

is

100-

total hepatic

fairly constant when systemic arterial blood

the total

that range the hepatic
able to

ligation of

and 160 mmHg.

total hepatic blood flow rapidly

160 mmHg

for if vaso¬

results described above.

pressure is maintained between 60
60 mmHg

in man.

the hepatic artery

"medical"

fatal

are

results

the hepatic artery

cause constriction of

would in effect’be a sudden

The

fact

liver's oxygen content so that eventually

the animal's hepatic artery and all of

(77)

the

falls,

flow rapidly increases,
arterial

(79)

to keep the

and a-

but within

and portal venous

interact in such a way as

Below

flows

total

flow

are

.
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stable under physiologic conditions.

The spleen helps to

keep the hepatic flow stable by compensating for changes
in mesenteric blood flow;

if the spleen is removed the

hepatic blood flow varies more markedly with changes in
systemic blood pressure.

(79)

Interestingly, a PCC>2 greater

than 56 also has been associated with a total hepatic blood
flow that is hypersensitive to changes in systemic blood
pressure.

(61)

It seems, however,

that the liver is

"over¬

perfused" in the sense that it is able to function normally
when its total blood flow is reduced by as much as 50%.
Although BSP removal falls proportionately with progressive
decline in hepatic blood flow, glucose metabolism and util¬
ization by the liver
(94)

(20)

and galactose uptake by the liver

are both unaffected by total hepatic blood flows as

low as 50% of normal in man and dogs.
however,

As we saw above,

it is necessary for the fall in total hepatic blood

flow to be secondary to a fall in portal venous flow,

since

the hepatic artery flow is crucial for hepatic oxygenation.
The status of sphincters within the hepatic vasculature
is still unclear; man most probably does not have hepatic
sphincters but the situation is less certain in other
mammals.

(83)

Bauer demonstrated thick muscular coats along

the hepatic vein near its junction with the inferior vena
cava in dogs and correlated this with a sphincter mechanism
stimulated by histamine which prevents the outflow of blood

{

.
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from the liver
Walker

(189)

(8);

similar conclusions were reached by

and Moreno

experimental model.

(125), both using the dog as an

Arey demonstrated circular and spiral

muscles in the tunica media of the central and small sublobular veins of dog using wax model reconstructions and
questioned whether their function was one of restricting
flow or of milking the veins to keep blood moving through
the liver.

(2)

In thirty mammals studied only the dog,

seal and racoon had this muscular arrangement.

(2)

Deysach

demonstrated muscular sphincters at the level of the sublobular vein and Knisely demonstrated them at the sinusoidal
level.

(189)

Thus,

it seems that the hepatic venous system

of dogs does have at least the potential for sphincter effects
at several different places.

(68)

This difference between

the dog's hepatic vasculature and man's will need to be
taken into consideration when trying to apply the results
from my experiment with dogs to a clinical situation with
man.
The hepatic nerve plexus receives fibres from the celiac
plexus,

the vagi,

and the right phrenic nerve.

(83)

The

vessels are innervated by both alpha and beta adrenergic
fibres as well as parasympathetic cholinergic fibres,

but

the most potent effect on the vessels is that of the alpha
adrenergic fibres.

(72;83)

Graded electrical stimulation

of single fibres of the hepatic plexus leads to a graded
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response of vasoconstriction in the hepatic artery imply¬
ing that each fibre controls the vasculature of only a small
part of the liver.

(29)

Stimulation of the entire hepatic

plexus lead to a marked decrease in hepatic artery flow
with an increase in hepatic artery pressure

(27), but as the

stimulation is maintained the hepatic artery "escapes" via
autoregulation and within five minutes the hepatic artery
flow is back to baseline values.

(83)

It seems that stim¬

ulation of the hepatic plexus has little effect on portal
venous flow although it does increase portal venous pressure.
(30;83)

As would be expected,

the in vivo isolated and

denervated liver lacks most of its vasomotor tone due to
its loss of predominantly alpha sympathetic stimulation.

(24)

The hepatic artery responds as would be expected to local
infusions of epinephrine and acetylcholine with vasoconstric¬
tion and vasodilatation respectively.

(74)

Infusion of epi¬

nephrine into the portal vein increased the portal venous
pressure.

(81)

Finally, Wakim used quartz-rod transillu¬

mination to visualize the hepatic sinusoids during hepatic
plexus stimulation in frogs and rats and noted marked con¬
striction of active sinusoids within two seconds of the
onset of stimulation.

(186)

Thus,

the hepatic plexus can

play a significant role in controlling hepatic artery blood
flow and therefore,

I was careful to preserve the plexus

during surgery in order to obtain results which are as
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accurate and physiologic as possible.
The gross distribution of the hepatic artery and
portal vein within the liver was described above but the
exact relationship between the smaller branches of these
vessels and the possible existence of intrahepatic shunts
are two questions which are not as easily answered.

It is

known that in the cirrhotic liver significant amounts of
blood pass from the hepatic artery to the portal vein
through dilated sinusoids.

(21;153)

As early as 1906, Mall

injected celloidin into the hepatic artery of normal mammal
livers and recovered the celloidin from the portal vein

(118)

implying the existence of a communication between the arterial
and venous systems.

Furthermore,

communications between

the hepato-portal systems have been visualized at the sinusoidal
level using quartz-rod transillumination in the amphibian,
rat and mouse.

(18;188)

We have already mentioned that

hepatic artery branches which supply the bile ducts and
connective tissue empty into the portal vein before it
reaches the hepatic sinusoids.

These anastomoses are less

than 50 microns in diameter and are of questionable func¬
tional significance.

(83)

Geumei claims to have demonstra¬

ted the presence of unidirectional pre-sinusoidal shunts
from the arterial to the venous system in isolated perfused
dog livers.

He found the sum of hepatic artery and portal

vein flows during independent perfusions to be greater than

.
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their total

flow during

that during

simultaneous perfusion part of

travels
venous

through shunts
flow.

simultaneous perfusion and claimed

to

the arterial blood

the portal vein and impedes

the

When he clamped the hepatic vein and perfused

through the hepatic artery the perfusate appeared

so rapidly

from the portal vein that he felt the shunt had to be presinusoidal based on temporal

factors.

through the portal vein all of
the hepatic vein and none was

When he perfused

the perfusate appeared in
found in the hepatic artery,

strongly implying that the shunt is uni-directional.
thermore,

Fur¬

when nylidrin was perfused through the hepatic

artery it effected arterial

and venous flow,

but when per¬

fused through the portal vein it effected only venous
again implying

a uni-directional

arterial perfusion pressure
all three vessels,
pressure

led

shunt.

Finally,

but increasing

portal venous perfusion
and portal venous

but decreased hepatic artery flow implying

(72;73)

able to pass

When Krypton

and hepatic

85

increasing

to an increase in flow in

increased hepatic venous

perfusate was

flow,

flow

that less

arterial

through the arterio-venous

is

shunts.

injected into the portal vein

artery both independently and simultaneously

the flow through the hepatic

artery is

always

than the flow through the portal vein and the
washout curve has been found
exponential components.

to have either

(16;92)

75%

slower

simultaneous

two or

three

This has been interpreted

as representing different channels

through the hepatic

sin-

.
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usoids;

the fast component represents pure portal vein channels,

the medium component represents
arterial

flows

are mixing,

represents pure hepatic
was

channels where venous

and the

third,

artery channels.

and

slow component,
(83)

Finally,

it

shown by Cohn that sinusoidal perfusion by the hepatic

artery is

as

extensive as perfusion by the portal vein

studied in the

intact dog.

He perfused labelled albumin

and labelled red blood cells

through each vessel

the ratio of Albumin/RBC perfusion time
each vessel.

In both cases

the transit time of

in a

itself

hematocrit,

the.hepatic sinusoids.

equal

its

ratio of

red blood cell
albumin to RBC

that

there are

the hepatic arterioles

space

time.

its

We have

lower

time would

not the case;

the

error.

(39)

Thus,

intra-hepatic communications between
and portal venules
level.

This

is

either at the

sin¬

an important point

reciprocal

arterial-

and autoregulation.
already discussed autoregulation within the

hepatic artery.
ciprocal

the

the hepatic

albumin

This was

as will become apparent as we discuss
flows

If

that

time for the portal vein and hepatic

usoidal or pre-sinusoidal

venous

albumin was

larger space with a

artery were identical within experimental
it seems

same for

implying

albumin distributes

artery bypassed the sinusoidal

and found

to be the

greater than that for the red blood cells

such as

as

Autoregulation is

also

involved with re¬

flows between the portal vein and hepatic

artery.

.
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As

early as

1911,

flow in the dog
flow was
(28)

Burton-Opitz found that hepatic artery

increased approximately 15% when portal venous

shunted away from the

Since that time several

in both the

intact and the

ing man and the dog)
pressure

is

is

toward the renal vein.

investigators have

isolated liver

a decrease in portal venous

while an increase

in hepatic

in hepatic

but not flow,

and portal vein.
response is

upon the

artery.

to

changes of

(83;169;179)

flow between the hepatic artery

It has been found

is

intact.

(39)

that the hepatic artery

The phenomenon

the hepatic vasculature and is

innervation of

the

supplies only 25% or so of

liver.

is

a local

not dependent

(8;39;156)

Since

crease in volume of portal venous

tent,

compensate for

the

it

the total hepatic blood flow,

the hepatic artery cannot completely compensate for

however,

This

less marked and slower in its onset when the

hepatic plexus
response of

Similar

seen in the portal

in response

flow and pressure in the hepatic
is what is known as reciprocal

are

flow and

artery flow.

(23;31;39;41;83;88;99;101;103;156;160;169;175)
but much less pronounced reactions

(includ¬

flow and

in portal venous

followed by a decrease

venous pressure,

shown that

in mammals

followed by a significant increase

arterial flow,
pressure

liver

loss

flow.

(23;83)

the de¬

It can,

of portal vein oxygen con¬

and we have already shown that the liver

normally at 50% of baseline portal venous

can function

flow(20;94)

if

.

33
its oxygen content is maintained.
The mechanism for the reciprocal

flow between portal

vein and hepatic artery is not perfectly understood.
most other organs of

the body autoregulation serves

metabolic function in that the
products

leads

to a decrease

In
a

accumulation of metabolic

in arterial resistance so

that

arterial flow can increase and wash out the metabolic pro¬
ducts.

Thus,

the metabolic theory of autoregulation is
implies

a

flow dependent one;

it

that an increase in venous

pressure would lead

to decreased flow and an accumulation

of metabolic products which would then cause a decrease
in arterial resistance and a secondary increase
flow.

In the

liver,

however,

increased hepatic venous

sure leads

to an increase

a decrease

in hepatic artery flow.

metabolic theory of
(83)

(83)

Therefore,

the

a^toregulation does not apply to the

to

a decrease

that the decrease

the hepatic artery is

able to increase

When one considers,

however,

between the hepatic

artery

liver.

in

in volumetric encroachment

by portal vein radicles on the hepatic artery and as

(@10mmHg)

pres¬

in hepatic artery resistance with

A second possible mechanism is

portal flow leads

in arterial

its

flow.

the difference

(@100mmHg)

and

it becomes hard to imagine the

a volumetric encroachment on the former.

a result

(156)

in pressures

the portal vein
latter exerting
(68)

A third possible

mechanism for the autoregulation and reciprocal flow is

that

.
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the increased arterial or venous pressure causes
capillary filtration with fluid accumulation

increased

in the extra-

vascular space which would

increase tissue hydrostatic pressure

and extrinsically compress

the hepatic blood vessels

their
for

flow.

This

seems

unlikely as

it would exert a qualitatively

arterial
flows

and venous

in the two

other.

flows,

the

in the

identical effect on the

while we already know that the

the effect on the portal venous

would be greater since it is

responses

however,

systems vary inversely with respect

Furthermore,

almost all of

the mechanism,

articles
arterial

reducing

thin walled,

referred to

to

each

system

but we know that

above

found greater

system.

The fourth possible mechanism is

the most

likely;

auto¬

regulation and reciprocal flow are probably the result of
a myogenic response by the
changes

in pressure.

terminal hepatic arterioles

We have already established that there

are either sinusoidal or pre-sinusoidal
between the hepatic arterial
we know that the sinusoidal
venous

system.

Thus,

hepatic vein can all
An increase

to

communications

and portal venous
system feeds

the hepatic artery,

into

systems

and

the hepatic

portal vein and

communicate via the hepatic sinusoids.

in the sinusoidal pressure either secondary to

increased hepatic vein pressure,

increased portal vein pressure

or increased hepatic artery pressure could lead to
crease in the rhythmic activity of

the

an in¬

smooth muscle

in the

.
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hepatic arteriole walls
hepatic

artery flow.

to sinusoidal
with this

causing vasoconstriction and decreased

Since the portal vein contributes more

flow than the hepatic artery

theory that changes

it

is

consistent

in portal venous pressure

45 times more effective than changes

in arterial pressure

in affecting hepatic arterial resistance and flow.
This

is

also

consistent with Nakata's

the total pressure gradient across

implying
(126)

that this region is

The myogenic

hepatic vein,
in the hepatic

ie.

theory of

(88)

that 40% of
is between the

the hepatic

important for

sinusoids

pressure changes.

autoregulation is

with the observed phenomena of
flow in the liver:

finding

the liver

portal venules and the central vein;

are

consistent

arterial-venous reciprocal

when pressure

increases

in either the

portal vein or hepatic artery the pressure
sinusoids

is

also elevated which elevates

the pressure in the hepatic arteriole resistance vessels
causing a myogenic constriction in these vessels.
pressure

is reduced

in either the hepatic vein,

When the

portal vein

or hepatic artery the sinusoidal pressure would secondarily
also be decreased as would the pressure in the
hepatic

arterioles

thereby decreasing
increasing

its

allowing

terminal

the myogenic response

the hepatic artery's resistance

flow.

(88)

to relax,
and

When the sinusoidal pressure

suddenly lowered the hepatic artery has
excess reactive hyperemia which

lasts

-

is

a brief period of

approximately 30

seconds

36.
(83)

I will refer back to

regulation when discussing
since

the

theory is

the

be dealing.

since
The

the

from my experiment

I would like

celiac axis

these are

to briefly

and superior mesen¬

the vessels with which we will

celiac and superior mesenteric arteries

formed from the ventral

segmental

omphalomesenteric arc of
segmental

the

the embryonic circulation.

arteries

are

arteries of the paired

dorsal aorta which constitute the arterial part of

ventral

auto¬

in interpreting my data.

angiography

anatomy of

teric artery,

the results

crucial

Before discussing
discuss

this myogenic mechanism of

These

are highly irregular in their

manner of origin which may account

for

the many anatomical

variations which occur between the

celiac artery and the SMA.

(115;139)
In dogs

the celiac trunk is

from the anterior abdominal
of

the

cates

first and second
into

12-15 mm long

aorta between the upper borders

lumbar vertebrae.

a common hepatic

artery,

In 20% of

comes off of

common hepatic artery.

hepatic
forwards
of

artery is
and to

animals

It then trifur¬

splenic artery and

gastric artery.
the

and arises

the

left

left gastric artery
(60)

The

common

3.5-4.1 mm in diameter and moves upwards,

the right from the celiac axis

six centimeters

to

the Porta of

arteries

to

the

total

the liver where it takes

a sharp turn forward and to the right,
four proper hepatic

for a

giving off

liver from its

two

to

convexity

.
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and then continues

to the right,

gastroduodenal artery.

forwards and downward as

The gastroduodenal artery gives off

one or two right gastro-epiploic arteries and
ates

in one or

two

ward and forward giving off
left gastric

upwards,

artery is

forwards

and usually arises
ally comes off of
is

from a study of

to the spleen.

2-3.5 mm in diameter and moves

and slightly to the

The right gastric

left from the celiac

to the upper part of

artery is

from the gastro-duodenal but occassiona proper hepatic

artery.

celiac angiograms

In man the hepatic artery,

The above data

in 24

normal dogs.

celiac axis

mesenteric arteries may be quite irregular.
200 human cadavers Michels

found

is

He describes

liver. (123)

twenty

(60)

on page A-l.

and superior
In his

study

that the celiac axis

and SMA conformed to textbook description in only
cases.

the

.2-.7mm in diameter

A celiac angiogram from one of my experiments

of

forward

It then arches down¬

several branches

axis giving off numerous branches
stomach.

arteries.

2-3 mm in diameter and moves

and to the left from the celiac axis.

The

then termin¬

superior pancreatico-duodenal

The splenic artery is

55%

six collateral pathways

to

of
the

In 175 selective celiac and SMA arteriograms

in man only 65% had the classical

textbook distributions.

(185)

include

The most common variations

artery arising
mesenteric

the

from the

the hepatic

left gastric artery or

artery;Grant found

the

superior

the right hepatic artery

.
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coming off of
autopsies.
anomaly.

the superior mesenteric artery

Woodburne found a 14%

(78;191)

incidence of

clinical

the

same

The celiac artery and SMA arising

a common trunk has been found in 1.4% of
autopsies.

in 12% of human

(115)

853

These arterial anomalies

significance of my results,

for

from

consecutive

increase the

if there

is

in¬

deed a danger of reduced hepatic artery blood flow with
secondary hepatic
vasopressin into
infusions,

ischemia during direct infusion of
the hepatic artery,

but also SMA and gastric artery infusions

would be contraindicated unless

the anomalous hepatic

artery could be identified and the
that the vasopressin could be
gin of

then not only celiac

the hepatic

is valuable

artery.

infused distally to the ori¬

All of

in a patient who is

need not be wasted
intra-arterial

if

catheter positioned so

this requires

time which

acutely bleeding and which

it could be established

infusion of vasopressin does

that direct

not represent

a threat to hepatic artery blood flow.

ANGIOGRAPHY

The principle of

infusing radio-opaque dye

into vessels

to delineate vascular lesions has been employed for many
years

in radiology.

It was

in 1963,

Nusbaum first investigated the use of
r

however,

that Baum and

angiography for

the

.
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demonstration of intra-abdominal bleeding from undetermined
sites.

(129)

They created bleeding points in the gastro¬

intestinal tract of dogs and then explored several different
techniques for localizing the bleeding site.

The injection

of 1^31 an£ p32 tagged albumin was no good because the back¬
ground count was too high to localize the bleeding site;
aortography via a midstream injection did not sufficiently
visualize the smaller arterial branches and involved the
use of high doses of contrast material;

retrograde aortography

after occlusion of the aorta with a balloon catheter above
the celiac axis visualized the peripheral branches well but
was a fairly dangerous procedure;

operative segmental arterio< -

grajphy was time consuming and dangerous requiring at least
ten intra-operative injections since each arcade needs to
be examined separately.

(10)

Percutaneous selective arterio¬

graphy via the femoral artery using the Seldinger technique
of catheter insertion

(163)

and radio-opaque polythene

catheters shaped by immersion in hot water as described
by Odman

(136)

was found to be an excellent procedure.

Using this technique Baum and Nusbaum were able to visualize
lesions bleeding at a rate as slow as 0.5cc/minute;
minimal amount of contrast material was needed.

only a

(10;129)

Vessels as small as 0.2mm in diameter can be readily visu¬
alized by this technique.

(60)

This technique is especially

valuable considering that in 20% of patients explored for

.
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an upper gastro-intestinal bleed and in 70% of patients
explored for

melena the surgeon cannot find a source of

bleeding; conventional radiology cannot demonstrate a source
of bleeding in 20-30% of cases.

(13)

Selective catheteri¬

zation is superior to gastroscopy and esophagoscopy in that
the latter procedures offer the examiner only a limited field
of vision,

and it is superior to conventional radiologic

techniques in that one cannot be sure that a lesion seen on
barium enema or upper gastro-intestinal series is actively
bleeding.

(11)

Using selective catheterization of the celiac,

superior mesenteric,

and inferipr mesenteric arteries both

individually and in combination the following bleeding sites
have been identified in patients by Baum and Nusbaum: Mallory
Weiss tears, gastric ulcer,
malformations,

duodenal ulcer,

splenic rupture,

arterial-venous

esophageal varices, pancreatic

carcinoma, hepatic carcinoma, gastric carcinoma,

colonic

carcinoma, pancreatic cysts, occlusive vascular disease,
pancreatitis,

arterial aneurysms, peri-cecal abscess, colonic

diverticulum,

and post operative bleeding from pseudo an¬

eurysms at anastamoses.

(10;11;12;13;16;131;184)

I have already discussed the use of■intra-arterial
infusions of vasopressin to control gastro-intestinal bleed¬
ing;

in retrospect this seems to be the logical next step

once the clinician has identified the bleeding site via
selective angiography.

The same catheter that had been

.
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used during angiography is used for the infusion of vaso¬
pressin;

the drug flows into the vessels just as the contrast

material did and therefore,

any bleeding site visualized

during angiography will be exposed to vasopressin during the
drug infusion.

It has also been hypothesized that small

blood clots from the tip of the catheter may help to occlude
the bleeding site.

(171)

Percutaneous selective angiography does entail certain
risks.

In a survey of 11,402 procedures from 204 hospitals

in the United States there were seven fatalities
81 serious complications
(3.0%).

(105)

(0.7%)

(0.06%),

and 325 minor complications

The fatalities were secondary to:

thrombosis

of the aorta, renal arteries or carotids; passage of the
catheter through an aortic coarctation;
with aortic rupture;

intramural injection

and pulmonary infarct secondary to

thrombosis of an inadvertantly punctured saphenous vein.
The serious complications included:

arterial thrombosis

either at the site of puncture or further along the path
of the catheter; broken catheter tip or guide wire embolus;
arterial embolization secondary to dislodged atheromatous
material or due to intimal damage with thrombus formation
and later embolization; perforation of major vessels with
large retroperitoneal hematomas;

and bowel ileus and

necrosis.

Temporary arterial spasms,

asymptomatic local

hematomas,

asymptomatic intramural or subintimal injections,

.
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and perforation of major vessels without late sequelae were
considered minor complications.

(.105)

Luke reported five

major complications during 372 procedures,

including severe

arterial embolization necessitating supracondylar amputation,
dissecting aneurysm, total obstruction of both popliteal
arteries by atherosclerotic debris and emboli, post angio¬
graphy claudication at 100 feet,
at the puncture site,

an orange-sized hematoma

and a myocardial infarction in a

patient with a previously normal EKG.

(114)

Haut reported

a complication rate of 1.8% in 1000 procedures, mainly due
to post catheterization vascular thrombosis.
noted thrombus formation

(by x-ray)

(89)

Formanek

in 54% of diagnostic pro¬

cedures and found that the thrombus formation was directly
proportional to the duration of the catheterization and not
related to the diameter of the catheter.

The thrombi form

rapidly, being seen in catheterizations as short as fifteen
minutes;

the thrombus forms as a sleeve around the catheter

and is peeled from the catheter and left in place in the
artery as the catheter is withdrawn.

(65)

Other complica¬

tions of selective arteriography include catheter migration,
bowel infarction,

cerebral vascular accidents,

spinal cord

paralysis, gall bladder infarction and renal damage.

(55)

Melnick noted that mechanical injection of contrast material
caused a brisk and forceful extension of the distal cathe¬
ter with a forceful return after the injection.

The force

.
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of

this

"whip" was proportional

intimal

lacerations

in dogs

at the point of

Thus,

selective

to

the

injection pressure;

and sub-intimal hematomas were found
the catheter's whipping impact.

arteriography is a useful

like all medical procedures

it does

technique,

entail

(121)

but

certain risks.

PERTINENT PREVIOUS WORK

Having provided the groundwork of
to intelligently evaluate

information required

and interpret my data,

now like to briefly discuss

I would

those experiments which were

concerned with a question similar to the one with which
have dealt;

ie.,

I

the effect of vasopressin on hepatic artery

blood flow.
Heimburger

infused vasopressin intravenously

and noted a 72% decrease
decrease

into dogs

in portal venous blood flow,

in portal venous pressure and a 34% decrease

patic vein flow.

The

changes

persisted for fifteen to

in portal pressure

twenty minutes
but the

total hepatic venous

flow was

followed by a gradual

initial decrease

in

rise

in

to pre-infusion baseline values while

infusion of vasopressin was

the fall in hepatic venous
portal venous

in he¬

after the vaso¬

stopped,

the

26%

and flow

pressin infusion was

flow almost returning

a

still in progress.

flow was

less

than the

Since
fall

in

flow Heimburger postulated that the hepatic

44.
artery blood flow had increased during
fusion to make up for

the vasopressin in¬

the difference between the venous

flows.

(90)
In 1956,
dogs

Kehne

infused vasopressin intravenously

and noted a 33%

decrease in portal venous pressure.

Kehne did not discuss
in the article he
sure of

infusion.

showed an

increase

but

in two graphs

in hepatic artery pres¬

140% of baseline value,

which would

in hepatic artery flow during vasopressin

(98)

Shoemaker
dogs

the hepatic artery,

approximately

imply a fall

into

injected vasopressin into the portal vein of

and noted a fall

in portal venous pressure and flow,

a rise

in systemic arterial blood pressure and a slight

crease

in hepatic artery resistance.

Since

the

increase

systemic blood pressure was much greater than the

in¬
in

increase

in hepatic artery resistance he hypothesized that there
would be an increase

in hepatic artery blood flow during

vasopressin infusions.
Drapanas

infused vasopressin

into the external
artery,

SMA,

flow probes.

(169)

jugular vein of dogs

and monitored hepatic

The blood flow in each of

blood flow was not as great as
but

15 minutes)

and portal vein blood flows with electromagnetic

during vasopressin infusion.

flow,

(10 units over

"a significant

The
the

fall

the vessels

fell

in hepatic artery

fall

(and sustained)

in portal vein blood
reduction in arterial

45.
inflow to the

liver was noted in all experiments"

vasopressin infusion.

during

(53)

Hanson infused vasopressin intravenously in dogs

and

monitored blood flows with electromagnetic flow probes.
He noted a 60%
tial decrease

decrease

in portal venous flow,

transient,

fall

and was

This

a

infusion
60%

decrease

followed by an increase
that at ten minutes

infusion hepatic artery blood flow was
baseline flow.

ini¬

in

in hepatic artery blood flow

hepatic artery blood flow so

in

into the

130% of pre-infusion

increase in hepatic artery blood flow

persisted throughout the remainder of
fusion.

the

to Heimburger's observations),

SMA flow and an initial
which was

35%

in total hepatic blood flow which then

increased toward baseline values during
(analogous

a

the vasopressin in¬

(87)

Shaldon infused vasopressin intravenously in patients
with and without porta-caval
in portal venous pressure,
blood flow,
a 77%

an

increase

87%

increase

shunts

a 40%

decrease

in total hepatic

in splanchnic resistance and

in hepatic arteriolar resistance

from wedged hepatic vein pressure).
arteriolar resistance
blood flow.

and noted a 39% decrease

implies

(as

The increase

calculated

in hepatic

a decrease in hepatic artery

(165)

Razzak infused vasopressin intravenously in dogs over
ten minutes

and noted an immediate fall

in portal vein

.
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pressure and hepatic vein blood flow.

The hepatic vein blood

flow began to return toward baseline values
way through the

less

than half

infusion while the portal venous pressure

remained low throughout the

infusion.

(as did Heimburger and Hanson)

Razzak hypothesized

that the return of hepatic

venous

flow toward baseline values was

crease

in hepatic artery blood flow.

secondary to

an in¬

(149)

Mahfouz perfused the anatomically isolated in situ
canine liver with vasopressin through the hepatic artery and
noted a 25% decrease

in hepatic artery blood flow and

20% decrease in portal venous blood flow.

a

When he perfused

through the portal vein there was no change

in the hepatic

artery blood flow and a 78% decrease in the portal venous
blood flow.

(117)

Cohen infused vasopressin intravenously into
monitored

splenic artery,

hepatic artery and

the splenic and

and

SMA blood flows

sequentially with electromagnetic flow probes.
caused constriction of

cats

Vasopressin

superior mesenteric

arteries with a decrease in their respective blood flows.
However,

the blood flow in the hepatic artery increased dur¬

ing the vasopressin infusion secondary to hepatic artery
vasodilatation.

(37)

Ericsson infused vasopressin intravenously in dogs
monitored blood flow with isotope

labelled microspheres.

He noted that vasopressin decreased blood

flow in the

and

.
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pancreas,

duodenum,

tongue,

lungs,

increased blood flow in the brain,
artery.

stomach and bowel but
eyes,

Even with marked decreases

blood flow to

kidney and hepatic

in the

the hepatic artery was

cardiac output

fairly constant and did

not decrease during vasopressin infusions.

(62;63)

Peter infused vasopressin intravenously and monitored
blood flow with electromagnetic flow probes
noted a 47.8% decrease

in portal venous

in gastric artery blood flow,
and

"inconsistent"

eral he

responses

in dogs.

flow,

He

a 67.8%

a 63.4% decrease

decrease

in SMA flow

in the hepatic artery.

In gen¬

found an immediate decrease in hepatic artery blood

flow during vasopressin infusion followed by a gradual
rise back toward pre-infusion baseline values.
of

five dogs

crease

did the hepatic artery blood flow actually

above baseline value

blood flow during

after its

initial decrease

the vasopressin infusion.

Aronsen performed celiac,
grams

In only one

in dogs before and during

in¬
in

(142)

SMA and portal vein angio¬
intravenous

infusions

vasopressin.

He

dilatation of

the main branches of the splenic,

of

found that vasopressin caused a vaso¬
gastric and

superior mesenteric arteries with decreased filling and
marked constriction of

their peripheral branches.

Only the

hepatic artery responded to vasopressin with an increased
filling of
branches.

its main branches
(3)

as well

as

its peripheral

Finally,

Nylander also

venously in dogs,

infused vasopressin intra¬

monitoring

the drug's effects with pre-

and post-infusion angiograms.
Aronsen's:

His results were

the central parts of

the splenic,

similar

gastric

to

and

superior mesenteric arteries dilated while their distal
parts,

including the gastroduodenal artery,

constricted during vasopressin infusion.
distal parts

of

but also

through it was

Not only was

the velocity of

increased,

flow of contrast material

it can be seen that there

agreement on vasopressin's

hepatic artery.

It seems

effect on the

that the overall effect of vaso¬

pressin on the hepatic artery is
investigators

in hepatic

(135)

From the above experiments

yet several

and

the hepatic artery

suggesting a decrease

artery vascular resistance.

is not 100%

The central

the hepatic artery were all dilated during

the vasopressin infusion.
dilated,

were markedly

one of vasodilatation,

in good experiments have

shown

vasopressin to cause hepatic artery vasoconstriction.
should be noted that in all of
intact animals

the vasopressin

the above experiments
was

infused

It
in

intravenously.

To the best of my knowledge no one has directly infused
vasopressin into the hepatic

artery while monitoring the

hepatic artery blood flow to follow the entire sequence
of vasopressin's
This

type of

effect in the

intact,

experiment would be useful

anesthetized mammal.
for two reasons:

.
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it would be a simple direct way of
happen when vasopressin comes
artery,

seeing exactly what does

in contact with the hepatic

and it would be simulating exactly what happens

in

man during direct intra-celiac infusion of vasopressin to
see whether or not the fear of hepatic ischemia secondary
to decreased hepatic artery blood flow during vasopressin
treatment of acute gastro-intestinal bleeding
Greenway,

in an excellent review article

the hepatic vascular bed
concluded that

in which he reviewed

"detailed knowledge of

in 1971

on

415 references

almost non¬

Few studies have been adequately controlled

and little attempt has been made
and indirect effects."

(83)

to differentiate direct

My review of

leaves me with the same impression;
vasopressin's
up some of

justified.

the mechanisms of

drug action on the hepatic vascular bed is
existent.

is

the

literature

hopefully my work on

effect on the hepatic artery will help

this

confusion.

to clear

.
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PART
The

I

intra-arterial

pitressin into the

infusion of

celiac axis

with electromagnetic

of dogs

flow probe moni¬

toring of blood flow in the hepatic
artery,

splenic artery and portal vein.

MATERIALS AND METHODS

Sixteen adult mongrel dogs of both sexes were used.
The animals were

starved for at least eighteen hours prior

to surgery but otherwise there were no special pre-surgical
preparations.
The following procedures

are described

in the order

in which they were performed.

ANESTHESIA:

The animals were anesthetized with sodium pentobarbi©
tol
as

(Nembutal

Abbott)

a single intravenous

became light during
intravenous
titrating

at an initial dose of
injection.

Those

25 mg/kg given

animals which

the experiment were given additional

injections of

25 mg of Nembutal at a time,

the frequency of Nembutal

injections with the

.
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animal's clinical
ments
line

response

and whimpers

as

judged by spontaneous move¬

and masseter muscle

tone.

An intravenous

in a brachial vein was kept open with normal

at a rate of

50

cc per hour to

saline

allow immediate intravenous

injection of Nembutal when needed.

INTUBATION:

Endotracheal

intubation was performed in all

animals

and respirations were controlled by a mechanical ventilator
at a volume

sufficient to maintain normal pulmonary move¬

ments and a rate of

sixteen breaths per minute.

ical ventilator operated on room air;

The mechan¬

no supplemental

oxygen was given.

ELECTROCARDIOGRAM:

Electrocardiogram needle
eously in all

four extremities

recorded via the

leads were inserted subcutan¬
and a standard limb lead was

350-3200 A ECG pre-amplifier channel of

a Sanborn recorder.

The electrocardiogram was monitored

throughout the experiment.

.
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ARTERIAL PRESSURE RECORDINGS:

A femoral
right

artery cutdown was performed distal

inguinal

ligament and the right femoral

isolated and ligated distally with 1-0
160

PE catheter was

until

its

tip was

then threaded into the

in the aorta,

by external approximation.
a pressure
on' the

silk.

The

a distance

to

the

artery was
A polythene

femoral

artery

judged roughly

catheter was

connected to

transducer and the aortic pressure was recorded

350-3000

born recorder.

c carrier pre-amplifier channel of
The Sanborn was

the

San¬

calibrated so that a de¬

flection of

four large

squares

represented an arterial

pressure of

200 mmHg.

Systemic arterial blood pressure was

monitored throughout the experiment;
catheter was
minutes

the blood pressure

flu-shed with 1 cc of normal

saline every fifteen

to prevent clot formation at the tip of

the catheter.

SELECTIVE CELIAC AXIS CATHETERIZATION:

A femoral
left inguinal

artery cutdown was
ligament and the

performed distal

left femoral

to

artery was

solated and carefully separated from the surrounding
ligating all

small branches with 5-0

technique of

catheter replacement was

silk.

the

The

i-

tissue,

Seldinger

employed to

introduce

the celiac axis

catheter into the femoral

artery.

(163)

The following equipment was used in this technique:
puncture needle with a diamond head stilette;
rounded end metal

leader,

and

$

a Form a cath

an outside diameter of

a flexible

the distal end of which is

more flexible than the rest of
a syringe;

0.045

the

leader;

general

inches.

The catheter was

of

approximately 6

the catheter formed a 135°
while

forming
cm.

1 cm.

the main stem of

artery was

the

from the

from the

the catheter was pointed approximately 170°

The femoral

cooling

angle with the rest of

the second bend,

opposite direction of

pre¬

so that the catheter had the

the first bend,

the catheter,

for

radio opaque catheter with

shape of a walking cane with two bends

distal curve;
tip of

(136)

even

an adapter

shaped by immersion in hot water followed by rapid
as described by Odman

a

tip

in the

the catheter.

ligated with 1-0

silk distal

to the intended site of puncture.

The puncture needle with

diamond head stilette in place was

then introduced into

femoral artery taking care to avoid puncture of
arterial wall.

advanced

A proximal

several

1-0

the rear

The diamond head stilette was withdrawn

one centimeter once in the femoral
was

the

centimeters

artery while

the needle

into the arterial

lumen.

silk tie around the femoral artery was used

to control bleeding

as

the diamond head stilette was

withdrawn and the flexible metal

leader was

introduced

54.
through the needle

several

inches

into the femoral

The needle was

then withdrawn and the catheter was

onto

leader

the metal

into the femoral

artery.
threaded

artery.

FLUOROSCOPY AND PORTABLE X-RAY:

Using the
scope

Siemens

Siremobile

the catheter was

the catheter as

one of

the aortic branches.

determine
tioned,

if

it was

it was pulled until

)

the first

then slowly pulled distally,

tating

(Hypaque

image intensifier fluoro-

advanced to a point beyond

lumbar vertebrae and was

diatrizoate

2

it

At that point 2

ro¬

"flowed"
cc.

of

into

60%

sodium

were injected into the catheter to

in the celiac axis.

a portable x-ray was

If properly posi¬

taken with the GE portable

x-ray machine using a Buckey table to allow more careful
examination of
was

the celiac axis.

A repeat portable x-ray

taken after the flow probes were

in place to make

sure

that they were on the right vessels.

The celiac catheter

was

entrance

then secured with 5-0

femoral

silk at its

artery and was attached to a 50 cc.

filled with normal

saline

fused at a rate of

approximately

into the

glass

syringe

in a Harvard infusion pump and in¬
0.05

cc/min.

to keep the

celiac catheter open and prevent clot formation at its
during the surgery.

tip

.
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ABDOMINAL SURGERY:

A midline

abdominal

xyphoid to pubis;
5-0

silk and the

incision was performed from

all bleeding vessels were tied with
abdominal cavity was not explored until

good hemostasis was obtained.
were

the Porta Hepatis.

carefully cleared of
cm.

distal

to

for an area of
celiac axis

surrounding

the union of

hepatic artery was
2

tissue for a

small

surrounding

The

tissue

approximately midway between the
Care was

taken to

arterial and venous branches

split the nerve fibres of

the hepatic plexus

and to

longitudinally

as not to disturb the physiologic neural effects of

hepatic plexus on the hepatic artery.
was then identified and a
its

length of

its main tributaries.

also cleared of

cm.

animal's

The portal vein was

and the Porta Hepatis.

avoid damaging

so

stomach and duodenum

then retracted caudally and toward the

left exposing

2

The

two main branches

main stem of

the

2

cm.

The

area was

the

splenic artery

cleared on one of

just distal to their union into the

splenic artery.

The

flow probes were

then placed on their respective vessels.

.
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FLOW METERS AND PROBES:

Five non-cannulating electromagnetic
used with internal diameters
and

8 mm.

In the

of

1.5 mm,

first eleven dogs

Electromagnetic flowmeter M4001 was
final dogs
units.
M4001

flow probes were

2 mm.,

studied only one
available,

studied there were three M4001

Each probe was
flowmeter units;

3 mm.,

calibrated for at

4 mm.
Statham

but with the

flowmeter power
least two of

each probe had its

the

own magnet current,

phase control and balance control which differed for each
meter used but which were easily determined by following
Statham's directions.
with the actual

To calibrate

flow in cc/min.

the flowmeter reading

passing through the

probe the probe was placed around a vessel
beaker of

saline;

allowed to pass

an additional amount of

through the vessel

and was measured.

In all

cases

segment in a
saline was

in a given period of time

a linear relationship was

found between flowmeter reading and actual vessel
cc/min.

(see diagram pageA-2 )•

every two weeks.
after

As

flow

flow in

Each probe was re-calibrated

a further check,

in every experiment

the probes were placed on their respective vessels

in the animal

the vessels were occluded with umbilical

tape

to make sure that zero flow corresponded with a reading of
zero on the flowmeter.

The flow probes were selected so

.
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as

to have a diameter

diameter.

slightly smaller than their vessels

In that way good

contact was maintained between

the flow probe and the vessel wall.
Once the flow probes were properly positioned
of

60% Hypaque

were again infused into

the

with fluoroscopic monitoring to make sure
had not fallen out of
of

Blood flows

tive vessels were monitored for one half hour
to stabilize prior

to starting

the manipulations

the catheter was

celiac axis when necessary.

catheter

that the catheter

the celiac axis during

surgery and probe placement;

in the

celiac

2 cc.

repositioned
in the respec¬

to allow them

the actual experiments.

VASOPRESSIN INFUSION:

In all groups vasopressin was

administered in the

form

<S>

of aqueous

Pitressin

(Parke-Davis)

standardized to contain

20 pressor units/cc.

One cc.

of normal

infused via the Harvard infusion pump

saline were

into the celiac catheter
of infusion differed
after the

of pitressin mixed with 9

in all

experiments;

in the different groups.

only the rate
Immediately

completion of each infusion the celiac axis was

visualized fluoroscopically with a 2
Hypaque

cc.'s

to make

cc.

injection of

sure that the celiac catheter had

in place throughout the pitressin infusion.

60%

stayed

.
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CONTROLS:

In each dog
pitressin were

studied 10

infusion rates

time while blood flows and

monitored just as
animal

saline without

infused either before or after the pitressin

infusion at identical
of

cc.'s of normal

served as

for equivalent amounts

systemic blood pressure were

in the actual experiments.

Thus,

each

its own control.

STATISTICAL ANALYSIS:

All results were expressed as percent change
(or pressure)

from the pre-infusion baseline value.

mean and standard error of
of

the data.

to

The

the mean were calculated for all

Comparisons were made between different groups

with the T-test for paired observations.
or equal

in flow

A P value

0.05 was considered significant.

were drawn to

show a range of

less

than

All graphs

two standard errors

above

and below the mean.

GROUP

I:

In all experiments
one cc.

of pitressin

in this group the animals received

(20 pressor units)

mixed with nine cc.'s

.
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of normal

saline

1 cc/min.

over

SUBGROUP
This

infused into the celiac axis

10 minutes

(ie.,

at a rate of

2 pressor units/minute).

I A:

subgroup consisted of

the hepatic artery of

two dogs.

Blood flow in

each dog was monitored continuously.

Systemic blood pressure was

also monitored

continuously.

Portal vein and splenic artery flows were not monitored.
SUBGROUP
This

I

B;

subgroup consisted of only one dog.

portal vein was monitored continuously as was
blood pressure.

Flow in the
systemic

Hepatic artery and splenic artery blood

flows were not monitored.
SUBGROUP
This

I C:

subgroup consisted of eight dogs

in which fifteen

separate vasopressin infusions were performed.
a sufficient number of

flow probes

but only one flowmeter was

for the

available.

There was

three vessels,

Therefore,

flows

in the three vessels were measured sequentially by switching
the different probes

into

the meter

in succession and

resetting the meter for the given probe.
it was possible to do
every 30
recorded;

seconds
eg.

blood flow,

With practice

this quickly and accurately so that

the flow in another vessel

could be

first a value was obtained for hepatic artery

then the portal vein probe was hooked into the

meter and a value obtained for its

flow,

then the

splenic

.
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artery was

connected to

the meter to determine

and then the hepatic artery was hooked
The probes were always
simply a matter of

its

flow

in again and

so on.

on their respective vessels,

it was

inserting

the wires

from each probe

into

the flowmeter in sequence.

GROUP

II:

These experiments were performed several weeks
the experiments

in group I.

cient number of

flowmeters

At this
as well

the flows

in the three vessels

ously and

simultaneously

SUBGROUP
This
as

subgroup consisted of
B)

flow probes,

so that

could be monitored continu¬
the experiments

cc.’s of normal
1

five dogs

with a total of

of pitressin

at a rate of

as

a suffi¬

in group II.

II A:

subgroup II

One cc.

in all

time there was

after

cc/min.

same dogs

six pitressin infusions.

(20 pressor units)

saline were

(the

infused

mixed with nine

into the celiac axis

(2 pressor units/min.)

over

10 minutes

in each dog.
SUBGROUP
This

II B:

subgroup consisted of

five pitressin infusions.
units)

five dogs with a total of

One cc.

of pitressin

mixed with nine cc.'s of normal

into the

celiac axis

at a rate of

(20 pressor

saline were

0.1 cc/min.

infused

(.2 pressor

.
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unit/min.)

For

over

a graphic

on page A-3•

60 minutes.

summary of

Part I experiments

see chart #1

.
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PART

II

The vascular response of
artery to vasopressin as
angiography

the hepatic

studied by celiac

in man.

MATERIALS AND METHODS

Materials

consisted of celiac axis

before and during celiac axis
compass

arteriograms

taken

infusion of pitressin and a

and a ruler for making measurements.

The celiac angiograms of
Kaven Veterans'

10 patients

from the West

Administration Hospital who underwent

vasopressin infusion to control gastro-intestinal bleeding
were examined.

Vessel diameters of

equivalent branches

of

the hepatic artery were measured before and after vasopressin
infusion.
a vessel
marker
done

It was

attempted

to compare

same branch of

at a given distance from a constant anatomical

in the pre- and post-vasopressin films.

in each case for either

or gastric arteries
artery changes.
1 cm.

the

distal

to

to

The

the gastroduodenal,

serve as

a comparison with

same was

splenic,
the hepatic

The hepatic artery main stem was measured
the origin of

the gastroduodenal artery.

The second order hepatic branches were measured 1 cm.

distal

to the

third

first branching of

the hepatic main stem.

The

.
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order hepatic branch diameters were measured 1

cm.

distal

to the branching of

The

fourth

the second order vessels.

order vessels were measured 1 cm.
of

the third order vessels

branches were measured as
distance distal

and the

distal to the branching
fifth order hepatic

accurately as possible at a fixed

to the fourth order branching.

The gastric

and splenic artery branches were measured in an analogous
manner to the hepatic artery.
however,

with only a

The gastroduodenal artery,

few true branches,

comparing diameter changes

was

analyzed by

at a given distance

gin from the hepatic artery.

See

from its ori¬

the diagram on page A-26.

.
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RESULTS

PART I:
In both groups

I

and

blood flow ranged from 27
mean value of

79.9

190.2

cc/min.

cc/min.;

flow ranged from 13
of

64.4

cc/min.

109.6 mmHg.

cc/min.

rapidly fall

with a

355

cc/min.

to

184

to

with a mean

splenic artery blood

cc/min.

with a mean value

systemic arterial blood
157 mrnHg with a mean value
the hepatic

artery

the total hepatic blood flow while the
70%.

the hepatic artery blood flow began to

after one minute of

the vasopressin to pass

infused at a rate of
44

cc/min.

SUBGROUP A:

In both dogs

of

to

Based on these figures

portal vein contributed

it takes

220

the baseline portal vein blood

and the baseline

contributed 30% of

GROUP I,

to

the baseline

pressure ranged from 50 mmHg
of

the baseline hepatic artery

cc/min.

cc/min.;

flow ranged from 62
value of

II

cc/min.

minutes of

to

1

cc/min.)

infusion

is how long

through the catheter when
from a mean baseline value

a mean low value of

infusion.

(which

13

cc/min.

at three

The hepatic blood flow then steadily

increased reaching a mean maximum flow of

83

minutes

This maximum

after the

infusion was

flow persisted for nine minutes

finished.

cc/min.

three

and then gradually returned

.
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to baseline value over thirty minutes.
experiments
than 5
A-4:
ously

showed no change

cc/min.

GROUP

in hepatic artery flow greater

in either direction.

"Mean hepatic artery blood

I,

2

PU/min.

for

(See graph

#1,

page

flow monitored continu¬

in two dogs during a total of

at a dose of

The two control

two pitressin infusions

10 minutes.")

SUBGROUP B:

In this dog the portal vein blood flow began to rapidly
fall

two minutes

after

the pitressin infusion was

from a baseline value of
cc/min.

at six minutes of

ed at this

low level

after the end of

the

after the

significant change
(See graph
monitored
of

#2,

I,

infusion.

infusion)

(ie.,

until

reaching a value of

in flow during

70

flow remain¬
2 minutes
flow

136 cc/min.

finished.

There was no

the saline

infusion.

"Portal vein flow continuously

for 10 minutes.")

SUBGROUP C :

In this

subgroup absolute

to percent change from baseline
A and B of group
C's data.

The portal

and then the portal

infusion was

page A-5:

to a low value of

in one dog during pitressin infusion at a dose

2 PU/min.

GROUP

cc/min.

for six minutes

progressively increased,
40 minutes

140

started

flow values were converted
flow.

Data from subgroups

I were included in the analysis of

subgroup

.
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The hepatic artery was
17

studied in 10 dogs

times during pitressin infusion and 12

saline

infusion.

a total of

times during

After one minute of pitressin

infusion

the mean hepatic artery blood flow suddenly fell
baseline flow

(P=0.00000050;

standard error=0.040)

ing a low value of

56% of baseline flow during

minute of

(P=0.00000355;

infusion

to

68%

of

reach¬

the third

standard error=0.066).

The mean hepatic artery blood flow then progressively increased,
reaching a mean value of
eighth minute of
and 141%
during

infusion

(P=0.0046;

the

130% of baseline
(P=0.035;

the

standard error=0.118)

standard error=0.083)

second minute after the

flow during

of baseline flow

infusion was over.

The

hepatic artery blood flow then gradually returned to baserline value over the next twenty minutes.

The saline control

infusions did not show a significant change
(

See graph #3,

page A6 :"Mean hepatic artery blood

monitored sequentially during
a dose of

2 PU/min.

for

The portal vein was

flow

17 pitressin infusions

at

10 minutes.")
studied in 9 dogs

times during pitressin infusion and 11
infusion.

in blood flow.

a

total of

times during

saline

After Ik minutes of pitressin infusion the por¬

tal blood flow began to fall reaching a mean flow of
of baseline flow

(P=0.00000239;

the sixth minute of
ed in this

16

infusion.

low range until

standard error=0.052)

54%
during

Mean portal vein flow remain¬

three minutes

after the

infusion

.
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was over at which time portal vein flow gradually increased
being at
0.093)

93% of baseline value

thirty minutes

(P=0.076,

after the infusion was

portal vein flow did not vary more
value during
page A-7:

the saline control

at

2

fusion

studied in

infusion.

from baseline
(See graph

#4,

8 dogs

a total of

times during

sa¬

After one minute of pitressin in¬

(at the same time that hepatic artery flow decreased)

splenic blood flow began
54% of baseline

during the

flow

was over,

sixth minute of

error=0.040)

fall reaching

infusion.

at which time the

increased being at

to

(P=0.00000040;

mained at approximately this

the

standard error=0.055)

low level until

saline control

the

infusion

splenic flow progressively

92% of baseline flow

fifteen minutes

a mean flow

The splenic flow re¬

after the

Splenic artery flow did not vary more
during

Mean

for 10 minutes.")

times during pitressin infusion and 10

line control

of

infusion.

PU/min.

The splenic artery was

the

than 7%

stopped.

"Portal vein flow monitored sequentially during

16 pitressin infusions

15

standard error=

infusion.

(P=0.0029;
infusion was

than

2%

standard
finished.

from baseline

(See graph

#5,

page A-8:

"Mean splenic artery blood flow monitored sequentially during
15 pitressin infusions

at a dose of

2 PU/min.

for 10 minutes.")

The mean systemic arterial blood pressure was
in 11 dogs
and 13

a total of

times during

18

times

studied

during pitressin infusion

saline control

infusions.

The blood

.
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pressure began to
infusion was

increase

started

flow decreased)

(at the

infusion.

level until

same time that portal vein blood

and reached a maximum value of

standard error=0.046)
minute of

1% minutes after the pitressin

The blood pressure remained at this

two minutes

after

after the

infusion was

the infusion was over.

(See graph #6,

page

at a dose of

In analyzing the

2 PU/min.

the saline control

:"Mean systemic

arterial

18 pitressin

for 10 minutes.)

sequence of events

in Group

I

that the hepatic artery and splenic artery reacted
to pitressin with a dramatic decrease
blood flows.

flow began to decrease.
increase

systemic

increase and the portal vein blood
This was

followed by a progressive

arterial blood pressure,

stopped,

splenic artery blood flow.

at which time all values

levels.

flow,

increased

decreased portal vein blood

ditions prevailed until several minutes

baseline

later the

increased hepatic artery blood

flow and decreased

was

immediately

in hepatic artery blood flow until a steady state

was reached of
systemic

it seems

in their respective

Approximately thirty seconds

blood pressure began to

at

Mean systemic blood

blood pressure monitored continuously during
infusions

stopped

reaching baseline value

pressure did not vary more than 4% during
infusion.

(P=0.00000Q18;

of baseline pressure during the eighth

which time the blood pressure fell,
15 minutes

136%

after

These
the

con¬

infusion

returned toward

their
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GROUP

II,

SUBGROUP A:

In this

subgroup the hepatic artery,

splenic artery,

portal vein and mean systemic blood pressure were monitored
simultaneously and continuously in five dogs during six
infusions

of pitressin

line control
to those

infusions.

in Group I,

so that all

(2 PU/min.
the

and five

conditions were

sa¬

identical

but now three flow meters were employed

three flows

at any given moment,

Thus,

for 10 min.)

could be observed simultaneously

removing any element of estimation

or guesswork.
One minute after

the pitressin infusion was

mean hepatic artery blood flow decreased to
flow

(P=0.0052;

standard error=0.113)

artery blood flow decreased to
standard error=0.117).
infusion was

started the

74% of baseline

and the mean splenic

56% -of baseline flow

Two minutes

(P=0.0068;

after the pitressin

started the mean systemic arterial blood pressure

began to increase and the portal vein blood flow began to
decrease;
started to
to fall.
was

at the same

increase while

the hepatic artery blood flow
the splenic

During the eighth minute of

reached:

line value

time

artery flow continued
infusion a steady state

mean hepatic artery blood flow was

(P=0.025;

standard error=0.071),

121% of base¬

mean splenic

artery blood flow was

39% of baseline value

standard error=0.068)

mean portal vein blood flow was

of baseline value

(P=0.0000028;

(P=0.00028;

standard error=0.031)

47%
and

.
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mean systemic blood pressure was

126% of baseline value

(P=0.0159;standard error=0.074).
flow remained elevated
was

for

The hepatic artery blood

five minutes

after the

infusion

finished and then gradually returned to baseline value

over the next fifteen minutes.

(See graph

#7,

pageA-10:

"Hepatic artery blood flow monitored continuously during
6 pitressin infusions

at a dose of

2 PU/min.

for

The portal vein flow remained depressed until

10 minutes.")

the

infusion

was over and then gradually increased,

being at 79% of

baseline flow thirty minutes

infusion was over.

(See graph #8,
uously during
for

the

page Adi:"Portal vein flow monitored contin¬
6 pitressin infusions

10 minutes.)

depressed until
increased,

after

The
the

being

at a dose of

2PU/min.

splenic artery blood flow remained

infusion was over and then gradually

at

85% of baseline flow thirty minutes

the infusion was* over.

(See araph #9,

pageA-12 :

after

"Splenic artery

blood flow monitored continuously during

6 pitressin infusions

at a dose of

The mean systemic

2 PU/min.

for 10 minutes.)

blood pressure remained elevated for two minutes
infusion was
line
A-13:

finished and

then gradually returned to base¬

level over the next ten minutes.
"Mean arterial

tinuously during
for 10 minutes.")

after the

(See graph #10,

page

systemic blood pressure monitored con¬

6 pitressin infusions
Blood flows

significantly during the

at a dose of

2

PU/min.

and pressure did not vary

saline control

infusions.

.
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Thus,
confirming

the results of Groups

flows

sequentially.

statistically the hepatic artery flows

infusion from Group I C

There was no

nificant difference between the
page A-14:

during

"Hepatic

17

during pitressin

statistically sig¬

two experiments.

(See graph

artery flow monitored continuously

6 pitressin infusions vs.

sequentially during

hepatic artery flow monitored

pitressin infusions.")

were obtained when the portal vein flows

Similar results

and splenic artery

flows were compared between the two experiments.
#12,

page A-15:

A-16:

16

"Splenic

portal vein flow monitored sequen¬

pitressin infusions."

See graph #13,

splenic artery flow monitored sequen¬

15 pitressin infusions.")

Since the results

from I C and II A were equivalent

and the experiments were performed under identical
except for monitoring
sequentially in
to analyze all

page

artery flow monitored continuously during

6 pitressin infusions vs.
tially during

(See graph

"Portal vein flow monitored continuously during

6 pitressin infusions vs.
tially during

To prove

and Group II A were analyzed and

graphed against each other.

#11,

analogous,

that we had not introduced significant error

in Group I C by evaluating the
this

I C and II A were

I C,
of

the flows

continuously in II A and

it was decided to combine

the responses to

of 20 pressor units of vasopressin.
pitressin infusion was

conditions

a ten minute
One minute

the

results

infusion
after the

started the mean hepatic artery blood

.
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flow decreased to

69% of baseline

standard error=0.041)
flow decreased to
error=0.050).

(P=0.00000024;

and the mean splenic artery blood

79% of baseline flow

At two minutes

hepatic artery flow was
0.00000407;

flow

as

after

low as

(P=0.00038;

the start of

the

65% of baseline

standard error=0.062)

standard
infusion

flow

(P=

but by three minutes

the

hepatic artery flow had already started to increase.

Mean

systemic arterial blood pressure began increasing 1% minutes
after the

start of

the pitressin infusion and portal vein

blood flow began falling

at the

same

blood flow continued to rise until
infusion was

136% of baseline

0.066).

The hepatic

flow

low as

0.040)

for 10 minutes.")

(See graph #14,

(See graph
infusions

#

(P=0.0000002;

the portal flow began to

15,

flow 30 minutes
page A-18:

at a dose of

artery flow fell

as

2

standard error=0.045)

and

at a dose

standard error=

the infusion was over
increase,

after the

being at

infusion was over.

"Portal vein flow during

PU/min.

low as

page A-17:

The portal vein flow went

and stayed at that level until

89% of baseline

standard error=

23 pitressin infusions

51% of baseline value

at which time

after the

flow then gradually returned to base¬

"Hepatic artery .flow during

as

two minutes

(P=0.00011;

line over the next 15 minutes.

2 PU/min.

The hepatic artery

stopped at which time the mean hepatic artery

flow was

of

time.

for 10 minutes.")

50% of baseline flow

22 pitressin
The splenic

(P=0.00000044;

stayed at that level until

the

in-

.
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fusion was over,
creased,

at which time the

reaching 90% of baseline flow 30 minutes

infusion was

stopped.

artery flow during
PU/min.

splenic artery flow in¬

(See graph #16,

page A-19:

21 pitressin infusions

for lOminutes.")

during

reaching a maximum value of
the eighth minute of

error=0.040).
until

the

at a dose of

lh

minutes of

infusion

(P=0.00000003;

The blood pressure remained at this

infusion was over at which time

The results
are analogous.

from Groups
The reader

to clarify the temporal
a ten minute

2 PU/min.

level

(See graph
24

#17,

page A-20

pitressin

II A and their combination

refered to graph #18,

changes

intra-celiac

standard

for 10 minutes.")

I C,

is

in¬

it returned to

"Mean systemic arterial blood pressure during
at a dose of

2

134% of baseline pressure

baseline values over twenty minutes.

infusions

"Splenic

The mean systemic blood pressure

progressively increased after the first
fusion,

after the

page A-21

in flow and pressure during

infusion of

20 pressor units of

vasopressin.

GROUP

II,

SUBGROUP B:

In this group the

same

six animals which were studied

in Group II

Subgroup A underwent a pitressin infusion at

the rate of

0.2

Pressor Units/minute

for

blood flows were monitored continuously.
more closely approximates

60 minutes while
This

dosage rate

the doses used clinically.

The hepatic artery blood flow began to decrease

three

.
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minutes

after the infusion was

level of
during

79% of baseline

the

flow

sixth minute of

gradually increased,
baseline flow

of flow until

infusion.

standard error=0.047)

The hepatic flow then

standard error=0.056)

infusion.
the

(P=0.010;

reaching a maximum value of

(P=0.019;

19th minute of

started and reached a low

during

It stayed at this general

45th minute of

level until

the

the
level

infusion when the hepatic

artery flow decreased to 111% of baseline flow.
at this

119% of

It stayed

infusion was over at which time the

hepatic flow returned to baseline values over 15 minutes.
(See graph #19,

pageA-22 :

continuously during
PU/min.

for

"Hepatic artery blood flow monitored

5 pitressin infusions

at a dose of

60 minutes.")

The portal vein blood flow began to decrease
after the infusion was
of baseline

flow

started,

reaching a

four minutes

low level of

(P=0.000010 ,* standard error=0.052)

it approximately remained until

the

81% of baseline value

stopped.

(See graph #20,

100 minutes
pageA-23 :

monitored continuously during
of 0.2

PU/min.

for

40%

where

infusion was over,

which time the portal vein flow increased reaching
of

0.2

at

a level

after the infusion was

"Portal vein blood

5 pitressin infusions

flow
at a dose

60 minutes.")

The splenic artery blood flow began to fall
after the infusion was

started

artery blood flow began to

three minutes

(exactly when the hepatic

fall)

and reached a low level

.
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fluctuating between 32%
standard error=0.072

and

21% of baseline values

and P=0.00000010;

respectively).

The

level until

infusion was

the

began to increase,
after the

splenic artery

reaching

infusion was

standard error=0.035

flow remained at

at a dose of

90% of baseline

over.

0.2

this

stopped at which time the flow

(See graph

flow 100 minutes

#21,

page A-24:

artery blood flow monitored continuously during
infusions

(P=0.000052;

PU/min.

for

5 pitressin

60 minutes.")

The mean systemic arterial blood pressure began
increase

four minutes

after the

infusion was

started

to
(at the

same time that the portal vein flow began to

fall)

a maximum value of

(P=0.045;

121% of baseline pressure

standard error=0.075)

where

"Splenic

it remained until

and reached

30 minutes

into

the infusion at which time the blood pressure gradually fell,
reaching baseline values
over.

(See graph

#22,

page A-25:

pressure monitored during
at a dose of

0.2

PU/min.

There was no
pressure during
responses

after the

the

infusion was

"Mean systemic arterial blood

5 pitressin infusions
for

60 minutes.)

significant change
saline control

in blood flows or systemic

infusions.

Thus,

the

to a lower dose of pitressin infused over a

prolonged period of
responses

time were qualitatively similar to

the

seen with the higher dose but shorter duration

infusions;
however,

10 minutes

the

changes

in vessel

were not as dramatic

flows

in the

and systemic pressure,

low dose

infusions

as

.
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they were

in the high dose

infusions.

PART II:

In all
branches

ten sets of

angiograms

studied

(first order through fifth order)

no change or an increase

the hepatic

artery

demonstrated either

in diameter when the vasopressin

infusion films were compared with the pre-infusion films.
The gastroduodenal
diameter throughout its

artery showed a marked decrease
length during

the vasopressin

in

infu¬

sions .
The splenic artery and gastric artery showed either
no change or an increase
(first order)
infusion.
arteries,

The

in the

in diameter of

films

Thus,

taken during the vasopressin

second through fifth order branches

however,

showed either a decrease

were totally absent during
chart #2,

their main stem branches

page a-27

of

these

in diameter or

the vasopressin infusions.

(See

& A-28)

intra-celiac vasopressin caused a marked constric¬

tion in the gastroduodenal artery and the peripheral branches
of

the splenic and gastric arteries,

upon the hepatic

artery and

but had little effect

its peripheral branches.

.
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GENERAL DISCUSSION

In this discussion

I

tionale of my procedures

shall be concerned with the ra¬
and the

I will not repeat theories
discussed
back to

in the

implications of my results.

and facts which were already

introduction;

the reader will be referred

that section when it seems

appropriate.

The dog was used as my experimental model because
of its

large

size and the

anatomy and man's.
the dog

similarity between its vascular

It should be recalled,

however,

that

liver does have muscular hepatic sphincters which

are not found in man's
the function of

liver.

(2;8;83;125;189)

these sphincters

that they do play a role

is not clear,

Although
it is possible

in intra-hepatic control of

liver

circulation.
Although
clinical

it would have been more applicable

situation in man if

the duration of
necessitated
Pentobarbital

(25 mg/kg)

cardiac output,
increase

(64)

heart rate,

sodium pentobarbital

surgery

anesthesia.

in dogs has been found to decrease

increase hepatic artery blood flow,

and decrease

(62)

both

splanchnic blood flow,

decrease mean systemic blood pressure,

arterial PC02

the

the animals were not anesthetized,

the procedure and the abdominal

the use of

to

and decrease basal body temperature.

increase

increase
(62;64;

.
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83;127;145)
was

In all cases,

transitory;

minutes

however,

all values

in spite of

the pentobarbital effect

returning

to normal within thirty

continued anesthesia.

Since

I did not

begin my vasopressin infusions until approximately two hours
after the
assuming

initial

anesthetic dose,

that all of

I

feel confident in

the vascular parameters were

stable and

that the pentobarbital did not distort my experimental
Since it is known that an arterial
56

is

PCC>2 greater than

associated with increased splanchnic vascular resistance

all of

the dogs were intubated and respirations were controlled

at a normal

level with a mechanical ventilator to

respiratory acidosis.

(61)

Furthermore,

found that vasopressin has
which differ from its
(62)

results.

special care was

effects

actions

since

avoid

it has been

in the hypovolemic dog

in the normovolemic animal

taken during surgery to achieve and

maintain good hemostasis;

in addition the animals were kept

well hydrated with normal

saline.

Catheterization was performed in the identical manner
as it is done

in man.

The

Seldinger technique

is

a rather

clean procedure with the advantage of being able to use a
small needle for a given catheter size.
catheter was radio opaque and held its
ature;

the

thinner tip made

(163)

The Formacath

shape at body temper¬

selective celiac catheterization

that much easier.

(136)

Hypaque contrast material

ported rapidly to

the kidneys

is

trans¬

and excreted unchanged in the

.
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urine,*

with normal renal

immediate.

(76)

This,

function elimination is

plus

the small hypaque bolus

the high dilutional

in the dog's

hypaque.

No

the catheter

secondary effects

from the

significant complications were encountered during

catheterization in the
The

effect of

intravascular volume,

allowed one to frequently check the position of
fluoroscopically without fear of

almost

anatomy of

sixteen animals

the celiac axis

studied.

in the dogs which

I

studied corresponded well with the description given by
Enge
(60)
into

in his

angiographic study of

In all

sixteen animals

the common hepatic

,

no anomalies were noted.
to disturb
possible;

the celiac axis

not

the celiac axis

left gastric,

in dogs.

trifurcated

and splenic arteries;

An attempt was made during
and porta hepatis

the hepatic plexus was

when cleaning the hepatic

the celiac axis

as

little

No

artery for probe placement so as

significant changes were noted

Hepatic artery

noted for approximately fifteen minutes

gery and flow probe placement.
allowed to

the

in blood pressure

and heart rate either during or after surgery.
spasm was

as

separated longitudinally

to distort the physiologic neuro-vascular tone of

vessel.

surgery

Blood flows,

after sur¬

therefore,

were

stabilize for thirty minutes before pitressin in¬

fusion was begun.
*

The three vessels
reasons;

flow changes

studied were chosen for the
in the hepatic artery,

of

following

course,

were

.
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my primary concern;
study the
liver to
cal

the portal vein flow was monitored to

interaction of
see if

the

there was

two afferent vessels of

indeed autoregulation with recipro¬

flow between the two vessels;

monitored to
artery.

the

serve as an arterial

the splenic artery was
comparison with the hepatic

The fact that both the hepatic and splenic arteries

originate from the same structure during embryonic develop¬
ment

(139)

yet respond differently to vasopressin

is quite

interesting and will be discussed later.
The electromagnetic flow probes

and meters were a rather

clean and accurate way of monitoring blood flow.

The electro¬

lytes of blood are charged particles which move between the
magnetic poles
of

in the flow probe and cut the magnetic

force at right angles,

thereby generating a voltage which

is registered by the flowmeter.
electrolytes

lines

Since

through a blood vessel

the flow of

is really an

charged

"endless"

moving electrolyte solution a steady potential difference
is recorded on the flowmeter.

Blood vessel wails have enough

electrical conductivity to permit placing the recording
lectrodes

e-

around the blood vessel without disturbing the

intravascular
blood vessel

space.

Contact between the electrodes

is not essential

from the space surrounding
flow voltage

passing

long as

the vessel.

is proportional

(volume of blood)

as

to

all

air

is

and the
excluded

The square wave

the number of electrolytes

through the magnetic field;

vessel

.
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size,

position and pulsation do not significantly effect the

operation of

the meter when mean flow is being evaluated.

When the meter and probe are well

calibrated there

is

a

linear relationship between flow and flow meter needle de¬
flection;

my calibration results were consistent with this

statement.
probes

(51;102)

It is

also possible to

in place while the animal

monitoring of blood flow in the

recovers

leave the flow

to allow continued

intact and awake

The effects of vasopressin were discussed
troduction.

Pitressin

(Parke-Davis)

of' the pressor principle of

is

in the

an aqueous

pressor units/cc.

It is

(76)

arterially over 10 minutes
over

sub¬

insipidus

The dosages used in my ex¬

than this;

20 pressor units

and 12 pressor units

intra¬

intra-arterially

60 minutes.
During the

was

stan¬

a day are usually

adequate to give a physiologic response in Diabetes

periments were much greater

in¬

solution

Five units

cutaneously or intramuscularly three times

or abdominal distention.

(146)

the posterior pituitary gland,

substantially free from the oxytocic principle.
dardized to contain 20

animal.

10 minute infusions

checked immediately after the

during the sixty minute

infusions

checked every twenty minutes;
throughout all of

the

the catheter position

infusion was over and
the catheter postion was

the catheter remained

infusions.

All

three

received an equal amount of hypaque before

in place

celiac vessels
the pitressin in-

.
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fusion was
most of

started;

once

the

infusion was begun,

the flow went to the hepatic

indeed monitoring

artery.

however,

Thus,

I was

the direct effect of vasopressin on hepatic

artery blood flow.
Results were expressed as percent change
values,

rather than as

statistical

absolute values,

comparison.

The

from pre-infusion

for the purpose of

absolute amount of

given vessel varied significantly from animal
depending on animal
The

change

analogous

size,

animals

to vasopressin,

in the vessels

control

is

Having

each animal

an ideal way to control

ence

this

serve

as

is

its own

all variables.

Conditions

infusions

addition of pitressin in the former;

in results between the two groups,

was

as percent change

were identical during the pitressin and saline
cept for the

however,

studied;

more clearly shown by expressing the results
from baseline value.

to animal,

vessel size and blood pressure.

in flow in response
in all

flow in a

ex¬

any differ¬

therefore,

can be

attributed to the pitressin.
I found the hepatic artery flow to be 30% of
liver blood flow while
of

the portal vein accounted

the flow during resting baseline measurements.

analogous

to

the distribution of

Furthermore,

artery flow to be

in Groups

increased 136%,

for 70%
This

is

flow between hepatic artery

and portal vein found by other investigators.
160;164)

the total

I C and II A,

(27;28;73;116;
I found hepatic

portal vein flow to be

.
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decreased 51%,

and splenic artery flow to be decreased 50%

of baseline values.

This corresponds well with the percent

change in flows found by other investigators during vaso¬
pressin infusion.

(87;90;142)

In the initial two dogs
was studied alone.

(Group I A)

the hepatic artery

The results were dramatic and significant;

allowing pitressin one minute to travel through the celiac
catheter the hepatic artery responded to the pitressin with
an immediate fall in blood flow.

This primary response,

however, was transient and was followed by a compensatory
increase in hepatic artery flow which persisted throughout
the pitressin infusion and then returned to baseline value.
The portal vein response in Group I B was also dramatic;
approximately

lh to 2 minutes after the start of the infusion

(which is enough time for the pitressin to travel through
the catheter and circulate through the dog's vascular system)
the portal vein flow fell and remained at a low level until
the infusion was over.
It was shown that the results of Group I C with sequen¬
tial monitoring of blood flow and Group II A with continuous
monitoring of blood flow were analagous with no statistically
significant difference between them.

In all cases the hepatic

artery and portal vein reacted as described above.
tion,

In addi¬

the splenic artery flow fell at the same time that the

hepatic artery flow fell, remaining at a low level throughout

84.
the infusion.
at the same
Thus,

time

dramatic.
causes

three vessels

the responses

studied plus

the

systemic

to high doses of pitressin

over a ten minute period were consistent and
The sequence of

events

is

as

follows:

Pitressin

a direct vasoconstriction with decreased blood flow

immediately upon arrival

in the hepatic artery and

artery;

as

seconds

the systemic blood pressure begins

the pitressin becomes

portal venous
fall

increased

that the portal vein flow fell.

in all

blood pressure
(2PU/min)

The mean systemic blood pressure

in venous

a steady state

flow falls.

splenic

systemic over the next thirty
to

increase and the

The hepatic artery responds

to

flow with an increase in its own flow so
is reached of

that

increased hepatic artery flow

and systemic blood pressure and decreased portal vein and
artery flows.

This

state persists

throughout the

returning to bas'eline value once the
changes

the

infusion,

infusion is over.

in flow and blood pressure were

splenic

The

statistically sig¬

nificant with P values much lower than 0.05.
The fall

in portal vein flow corresponded temporally

with the rise in systemic blood pressure,

and therefore,

it was most likely

due to splanchnic vasoconstriction and

decreased SMA,

splenic

flows.

IMA,

artery and gastric artery blood

This pre-portal effect of vasopressin on the portal

vein blood flow has been noted by many other observers.
57;83;47;134;142;169;178)

Nevertheless,

(4;32;36;

I cannot rule out

.
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at least a minor direct effect of vasopressin on the portal
vein.
The

initial response of

(decreased blood flow)
on the rest of
however,
begins
This

has

to

the

is

the hepatic and splenic arteries

consistent with vasopressin's

splanchnic arteries.

a secondary response;

fall

the hepatic artery's

is entirely consistent with

reciprocal

as

effect

The hepatic artery,

the portal vein flow

flow begins

the myogenic

to rise.

theory of

flow between the hepatic artery and portal vein

which was

discussed in detail

According

to this

theory,

as

in the

introduction

the portal venous

the pressure within the hepatic sinusoids
the terminal hepatic
sinusoids detect this

(page

flow decreases

also decreases;

arterioles which communicate with
fall

with a vasodilatation of

in sinusoidal pressure

the

33).

the

and respond

arterial resistance vessels,

increasing hepatic artery blood flow via this myogenic mech¬
anism.

The

origin as

fact that the hepatic artery has

the other splanchnic arteries,

erently to vasopressin,
is

the

interesting.

same embryologic

yet responds diff¬
Even more

amazing

angiographic demonstration that the gastroduodenal

artery,
responds
This

is

the

which is

actually a branch of

the hepatic artery,

to vasopressin with a prolonged vasoconstriction.

strongly implies

that the

the hepatic artery lies

autoregulatory mechanism of

in its distal branches within the

liver and not in the main stem of

the

artery which is

so

.
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closely related ontogenetically to the other splanchnic vessels;
ie.,

it supports

the

sinusoidal-myogenic theory of hepatic

artery_ autoregulation.
It should be noted that the
blood flow to

of

while the fall

51% of baseline value

flow 36%

in hepatic artery

136% of baseline value will only increase

liver blood flow 11%,
flow to

increase

lowers

total

in portal vein blood
the total

liver blood

(assuming that the hepatic artery contributes

30%

total hepatic blood flow and the portal vein contributes

the rest).

Thus,

during

blood flow is only 75% of
in the

introduction,

the pitressin infusion total hepatic
its baseline value.

however,

that the

tion normally when portal venous
(20;94)

It is

liver is

the

shown

able to func¬

flow is decreased by 50%.

the oxygen content of

the liver,

mainly provided by the hepatic artery,
(48)

We have

which is

which

is

critical;

increased hepatic artery blood flow during vaso¬

pressin infusion adequately maintains
tent and protects

the

liver's oxygen con¬

against ischemia.

My results do help to clarify the confusion created by
past experiments

in this

area.

I have confirmed the

ly concluded hypothesis of Keimberger
Shoemaker

(169)

vasopressin.
work

(87)

(90)

that hepatic artery flow is

My results

including

are

in total

indirect¬

Razzak(149)

and

increased by

agreement with Hanson's

the percent changes

in vessel

flows

(he found a 60% decrease in-portal vein flow and a 130%

.
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increase
of

51%

in hepatic artery flow as

and 136%

Aronsen

(3),

striction of

respectively).

and Nylander

compared with my values

Cohen

(135)

(37),

Ericsson

missed the primary vasocon¬

the hepatic artery but did note

vasodilatation during vasopressin infusion.
other investigators
intravenously.
the

to

This

celiac axis,

pressin at the
fall

in this

field,

only tends

SMA and IMA all

same time.

at the same

Thus,

time that

(62;63),

the secondary
They,

like all

infused the vasopressin

to confuse

the results,

since

are effected by the vaso¬
the portal vein flow begins

the hepatic artery flow starts

to fall,

the

former stimulating the myogenic autoregulatory

response

in the terminal hepatic arterioles which then inhibits

the primary vasoconstrictive effect of vasopressin on the
hepatic artery.
Kehne

(98),

Peter's results were

Drapanas

(53),

Shaldon

inconsistent

(165)

and Mahfouz

had results which were contradictory to mine;
to explain why this
43

is

so.

The reader

for a more detailed description of
The pitressin infusions

to the clinical
bleeding;

dose of

the pitressin dose was

(117)

am unable

is referred to page
these experiments.

treatment of gastro-intestinal
0.2

PU/min.

and the

infusion

so that each animal received a total

12 pressor units of pitressin.

qualitatively similar
pressin,

I

and

in Group II B were more analogous

situation in the

lasted for one hour,

(142)

but were much

to

The results were

the higher dose

less dramatic.

infusions of vaso¬

The fall

in hepatic

88
artery blood flow preceded the rise in systemic blood pressure
and consequent fall in portal vein flow.

The hepatic artery

flow then increased to 119% of its baseline value.

All flow

changes were statistically significant with P values less
than 0.05.

Thirty minutes after the infusion started, however

the systemic blood pressure gradually fell and returned to
baseline level.

Fifteen minutes later the hepatic artery

blood flow fell to 111% of baseline level and stayed at that
level until the infusion was over,

at which time the hepatic

artery flow returned to baseline value.

Thus,

there were two

major differences between the high dose short duration and
low dose long duration infusions:

the changes in flow and

pressure were more dramatic in the former,

and the systemic

blood pressure did not remain elevated throughout the entire
infusion in the latter.

Furthermore,

there was a slight

decrease in hepatic artery flow toward the end of the long
infusion, but this was not significant and hepatic artery
flow was still significantly greater than baseline flow.
In trying to explain the return of blood pressure to
baseline during the long infusions one might hypothesize
tiring of the vascular muscles with a consequent vasodilata¬
tion and decrease in blood pressure.

However,

the splenic

artery and portal vein flows remained low during this period
implying that the splanchnic vessels remained constricted
and that if there was a vasodilatory effect it was restricted

.

89
to the peripheral arteries.

It must be remembered,

hov;ever,

that these were long procedures taking approximately a total
of six hours during which time the dog's abdomen was opened.
Although the abdominal wound was covered with saline soaked
towels,

there was still a significant evaporative cooling

effect upon the animal which may have contributed to the fall
in blood pressure.

This would also explain why the post¬

infusion flow in all three vessels was lower than the pre¬
infusion flow in the long infusion experiments.
The celiac angiograms from patients receiving vasopressin
infusion revealed peripheral vasoconstriction of all
branches of the gastric and splenic arteries in addition
to constriction of the entire gastroduodenal artery while
the hepatic artery and its branches were unchanged or actually
slightly vasodilated.
by Nylander in dogs

This is in agreement with the work done

(135)

and further confirms the unique

secondary response of the hepatic artery to vasopressin
infusion.

This response in man, being identical to the

response of the hepatic artery in dogs,

is additional support

in arguing that vasopressin does not represent a threat to
hepatic artery blood flow.
There are several additional experiments which might
be useful to perform in this area.
(62)

It has been reported

that hypovolemic dogs respond to vasopressin differently

than normovolemic dogs.

In view of the fact that many patients

.
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who would require vasopressin infusions are hypovolemic secon¬
dary to their acute gastro-intestinal bleeds it would be

^

useful to bleed dogs down to a given blood pressure and then
repeat the experiments which I have performed.

It would

also be useful to study the effect of intra-celiac infusions
of vasopressin in the awake dog.

This could be done by placing

the flow probes on their respective vessels and then allow¬
ing the animals to recover over several weeks with the probes
in place.

(146)

Using animals trained to lie still,

and

local anesthesia for the femoral artery cutdown, one could
then repeat the experiments which I performed under conditions
even more similar to those used with man.

It would also be

interesting to repeat the experiments which I performed but
in addition take liver biopsies to confirm the absence of
hepatic necrosis.
interesting,

Although the latter experiment would be

it is probably not necessary in view of the

clearcut results from my experiments; hepatic necrosis would
most likely not be found.

.
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SUMMARY

The effect of intra-celiac infusion of vasopressin on
hepatic artery blood flow was studied 28 times in 15 dogs
using non-cannulating electromagnetic flow probes.
vein flow,

Portal

splenic artery flow and systemic blood pressure

were also monitored.

Normal saline infusions without vaso¬

pressin served as controls in every animal studied.
Results were consistent in all animals.

Initially,

hepatic artery flow fell to 65 percent of baseline and splenic
artery flow fell to 50 percent of baseline values.

Over

the next 30 to 60 seconds systemic blood pressure began to
rise reaching a value of 134 percent of baseline and portal
vein flow fell to 51 percent of baseline.

As portal vein

flow fell hepatic artery flow increased, reaching a value
of 136 percent of baseline flow.
hepatic artery blood flow,

This state of increased

increased systemic blood pressure,

decreased portal vein blood flow,

and decreased splenic artery

blood flow persisted throughout the remainder of the vaso¬
pressin infusion.

All values returned to baseline post¬

infusion .
Angiograms from ten patients who underwent celiac axis
infusion of vasopressin were also studied.
angiograms showed no change

Post vasopressin

(or an actual increase)

in hepatic
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artery diameters while the splenic,

gastric,

and gastro¬

duodenal arteries showed marked peripheral vasoconstric¬
tion.
On the basis of this study as well as evidence from
the published studies of others,

it is concluded that the

hepatic artery responds to vasopressin with an initial vaso¬
constriction and fall in blood flow which is followed by
vasodilatation and increased hepatic artery flow secondary
to a myogenic autoregulatory response in the hepatic arter¬
ioles.

This myogenic response is triggered by the fall in

hepatic sinusoid pressure which results from the fall in
portal vein blood flow secondary to pre-portal vasoconstric¬
tion caused by vasopressin.

The initial fall in hepatic

artery flow also helps to trigger the myogenic vasodilatation
The unique secondary increase in hepatic artery blood flow
enables it to deliver more oxygen to the liver,

thereby

maintaining the liver's oxygen content and protecting it
against ischemia and necrosis in spite of the decrease in
portal vein flow.
In view of the uniform results during infusion of vaso¬
pressin in dogs,

and in view of the clinical confirmation

supplied by angiograms of ten patients who underwent celiac
axis infusion of vasopressin,

it is felt that direct celiac

infusion of vasopressin does not necessarily represent a
threat to hepatic artery flow.

If the clinical situation

dictates,

vasopressin can be

infused directly into

celiac axis without causing hepatic
compensatory dilatation of

ischemia,

the main

provided

the hepatic artery occurs,

documented by angiography after a brief

trial.

as

.
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Angiograms ,
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